How many Relatlimab clinical trials are there?

90 Relatlimab clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 29 are actively recruiting participants. 24 are marked completed.

Are Relatlimab clinical trials recruiting in 2026?

Yes — 29 Relatlimab trials are actively recruiting in 2026, with 843 U.S. sites across 48 states. See the recruiting trials and the per-state site list further down this page.

What conditions is Relatlimab being studied for?

Relatlimab is being studied for Melanoma, Metastatic Melanoma, Advanced Melanoma, Advanced Cancer, Gastric Cancer and 207 more. The trials are grouped by indication on this page.

What phase is Relatlimab in?

Relatlimab clinical trials span 2 Phase 4, 8 Phase 3, 48 Phase 2, 11 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.

Who sponsors Relatlimab clinical trials?

The lead sponsor across the most Relatlimab trials is Bristol-Myers Squibb, with 37 additional lead sponsors listed in the data. Each trial row links to the full study detail page including sponsor information.

Relatlimab Clinical Trials (2026): 90 Studies for Melanoma & Metastatic Melanoma

Creator: Hipa.ai Research
Published: 2026-05-26T17:47:30.196Z

Hipa.ai Research · Source: ClinicalTrials.gov / AACT

Synced daily from ClinicalTrials.gov via AACT. Last sync: June 12, 2026.

90 Relatlimab clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 56 indications (including Melanoma & Metastatic Melanoma) and 25,143 total planned enrollment. 8 Phase 3 Relatlimab trials and 48 Phase 2, 2 Phase 4 are listed. 33 Relatlimab clinical trials are actively recruiting at 843 U.S. sites across 48 states. Most recent activity: NCT07369791 (Dec 2040).

Where to Participate: All Relatlimab Trial Sites in the U.S. (843 sites across 48 states)

Every actively recruiting Relatlimabtrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.

State	Facility	City	Trial	Map
AZ	Ironwood Cancer & Research Centers	Chandler85224	NCT06246916	Map
AZ	Banner MD Anderson Cancer Center	Gilbert85234	NCT06246916	Map
AZ	Banner MD Anderson Cancer Center	Gilbert85234	NCT06264180	Map
AZ	Cancer Center at Saint Joseph's	Phoenix85004	NCT05987241	Map
AZ	Exelixis Clinical Site #67	Phoenix85054	NCT05176483	Map
AZ	Mayo Clinic	Phoenix85054	NCT06743126	Map
AZ	Mayo Clinic Hospital in Arizona	Phoenix85054	NCT05987241	Map
AZ	Honor Health Research Institute	Scottsdale85258	NCT06743126	Map
AZ	Banner University Medical Center - Tucson	Tucson85719	NCT05987241	Map
AZ	Exelixis Clinical Site #1	Tucson85711	NCT05176483	Map
AZ	Southern Arizona VA Health Care System	Tucson85723	NCT06561386	Map
AZ	University of Arizona	Tucson85720	NCT06112314	Map
AZ	University of Arizona Cancer Center-North Campus	Tucson85719	NCT05987241	Map
AR	Highlands Oncology Group - Fayetteville	Fayetteville72703	NCT05987241	Map
AR	University of Arkansas for Medical Sciences	Little Rock72205	NCT06246916	Map
AR	Highlands Oncology Group - Rogers	Rogers72758	NCT05987241	Map
AR	Highlands Oncology Group	Springdale72762	NCT05987241	Map
CA	Kaiser Permanente-Anaheim	Anaheim92806	NCT05987241	Map
CA	Kaiser Permanente-Baldwin Park	Baldwin Park91706	NCT05987241	Map
CA	Kaiser Permanente-Bellflower	Bellflower90706	NCT05987241	Map
CA	City of Hope National Medical Center	Duarte91010	NCT06743126	Map
CA	Kaiser Permanente Dublin	Dublin94568	NCT05987241	Map
CA	Kaiser Permanente Dublin	Dublin94568	NCT06029270	Map
CA	Kaiser Permanente-Fontana	Fontana92335	NCT05987241	Map
CA	Kaiser Permanente-Fremont	Fremont94538	NCT05987241	Map
CA	Kaiser Permanente-Fremont	Fremont94538	NCT06029270	Map
CA	Kaiser Permanente Fresno Orchard Plaza	Fresno93720	NCT05987241	Map
CA	Kaiser Permanente Fresno Orchard Plaza	Fresno93720	NCT06029270	Map
CA	Kaiser Permanente-Fresno	Fresno93720	NCT05987241	Map
CA	Kaiser Permanente-Fresno	Fresno93720	NCT06029270	Map
CA	Providence Medical Foundation	Fullerton92835	NCT06246916	Map
CA	Kaiser Permanente South Bay	Harbor City90710	NCT05987241	Map
CA	Kaiser Permanente-Irvine	Irvine92618	NCT05987241	Map
CA	University of California, Irvine	Irvine92868	NCT06624475	Map
CA	University of California, Irvine (UCI) Health - UC Irvine Medical Center	Irvine92612	NCT06697197	Map
CA	UC San Diego Moores Cancer Center	La Jolla92093	NCT05987241	Map
CA	UC San Diego Moores Cancer Center	La Jolla92037	NCT06264180	Map
CA	UC San Diego Moores Cancer Center	La Jolla92093	NCT06743126	Map
CA	University of California - San Diego	La Jolla92093-0698	NCT06112314	Map
CA	University of California, San Diego Moores Cancer Center	La Jolla92093	NCT06624475	Map
CA	Cancer and Blood Specialty Clinic	Los Alamitos90720	NCT06246916	Map
CA	ESC Norris Comprehensive Cancer Center	Los Angeles90033	NCT06112314	Map
CA	Kaiser Permanente Los Angeles Medical Center	Los Angeles90027	NCT05987241	Map
CA	Kaiser Permanente West Los Angeles	Los Angeles90034	NCT05987241	Map
CA	Keck Medicine of USC Koreatown	Los Angeles90020	NCT06029270	Map
CA	Los Angeles General Medical Center	Los Angeles90033	NCT06029270	Map
CA	The Angeles Clinic and Research Institute	Los Angeles90025	NCT06264180	Map
CA	The Angeles Clinic and Research Institute - West Los Angeles Office	Los Angeles90025	NCT06697197	Map
CA	The Angeles Clinic and Research Institute- West Los Angeles	Los Angeles90025	NCT06112314	Map
CA	The Angeles Clinic at Cedars Sinai	Los Angeles90025	NCT05428007	Map
CA	UCLA / Jonsson Comprehensive Cancer Center	Los Angeles90095	NCT05987241	Map
CA	UCLA Department of Medicine - Hematology/Oncology	Los Angeles90095	NCT06264180	Map
CA	UCLA Hematology/Oncology	Los Angeles90095	NCT06112314	Map
CA	UCLA Hematology/Oncology	Los Angeles90024	NCT06743126	Map
CA	University of California Los Angeles	Los Angeles90024	NCT06246916	Map
CA	USC / Norris Comprehensive Cancer Center	Los Angeles90033	NCT06029270	Map
CA	USC Norris Comprehensive Cancer Center	Los Angeles90033	NCT06264180	Map
CA	Kaiser Permanente- Modesto MOB II	Modesto95356	NCT05987241	Map
CA	Kaiser Permanente- Modesto MOB II	Modesto95356	NCT06029270	Map
CA	Kaiser Permanente-Modesto	Modesto95356	NCT05987241	Map
CA	Kaiser Permanente-Modesto	Modesto95356	NCT06029270	Map
CA	USC Newport Beach	Newport Beach92663	NCT06624644	Map
CA	USC Norris Oncology/Hematology-Newport Beach	Newport Beach92663	NCT06029270	Map
CA	Kaiser Permanente-Oakland	Oakland94611	NCT05987241	Map
CA	Kaiser Permanente-Oakland	Oakland94611	NCT06029270	Map
CA	Kaiser Permanente-Ontario	Ontario91761	NCT05987241	Map
CA	St. Joseph Hospital Orange	Orange92868	NCT06246916	Map
CA	UC Irvine Health, Chao Family Comprehensive Cancer Center	Orange92868	NCT06264180	Map
CA	University of California Irvine, UCI Medical Center	Orange92868	NCT06246916	Map
CA	Exelixis Clinical Site #123	Palo Alto94304	NCT05176483	Map
CA	Stanford Cancer Institute	Palo Alto94304	NCT06264180	Map
CA	Stanford Cancer Institute Palo Alto	Palo Alto94304	NCT05987241	Map
CA	Stanford Cancer Institute Palo Alto	Palo Alto94304	NCT06029270	Map
CA	Stanford University	Palo Alto94304	NCT06712927	Map
CA	Kaiser Permanente - Panorama City	Panorama City91402	NCT05987241	Map
CA	Emad Ibrahim, MD, Inc.	Redlands92373	NCT06246916	Map
CA	Kaiser Permanente-Riverside	Riverside92505	NCT05987241	Map
CA	Kaiser Permanente-Roseville	Roseville95661	NCT05987241	Map
CA	Kaiser Permanente-Roseville	Roseville95661	NCT06029270	Map
CA	Kaiser Permanente Downtown Commons	Sacramento95814	NCT05987241	Map
CA	Kaiser Permanente Downtown Commons	Sacramento95814	NCT06029270	Map
CA	Kaiser Permanente-South Sacramento	Sacramento95823	NCT05987241	Map
CA	Kaiser Permanente-South Sacramento	Sacramento95823	NCT06029270	Map
CA	Sutter Health	Sacramento95816	NCT06246916	Map
CA	University of California Davis (UC Davis) Comprehensive Cancer Center	Sacramento95817	NCT06561386	Map
CA	University of California Davis Comprehensive Cancer Center	Sacramento95817	NCT05987241	Map
CA	University of California Davis Comprehensive Cancer Center	Sacramento95817	NCT06029270	Map
CA	Kaiser Permanente-San Diego Zion	San Diego92120	NCT05987241	Map
CA	Kaiser Permanente-San Francisco	San Francisco94115	NCT05987241	Map
CA	Kaiser Permanente-San Francisco	San Francisco94115	NCT06029270	Map
CA	San Francisco Oncology Associates	San Francisco94115	NCT06264180	Map
CA	San Francisco Oncology Associates	San Francisco94115	NCT06561386	Map
CA	UCSF	San Francisco94143	NCT06624644	Map
CA	UCSF Helen Diller Family Comprehensive Cancer Center	San Francisco94143	NCT06264180	Map
CA	UCSF Helen Diller Family Comprehensive Cancer Center	San Francisco94143	NCT06743126	Map
CA	University of California San Francisco (UCSF)	San Francisco94143	NCT06246916	Map
CA	University of California, San Francisco	San Francisco94158	NCT06624475	Map
CA	Kaiser Permanente-Santa Teresa-San Jose	San Jose95119	NCT05987241	Map
CA	Kaiser Permanente-Santa Teresa-San Jose	San Jose95119	NCT06029270	Map
CA	Kaiser Permanente San Leandro	San Leandro94577	NCT05987241	Map
CA	Kaiser Permanente San Leandro	San Leandro94577	NCT06029270	Map
CA	Kaiser Permanente-San Marcos	San Marcos92078	NCT05987241	Map
CA	Kaiser San Rafael-Gallinas	San Rafael94903	NCT05987241	Map
CA	Kaiser San Rafael-Gallinas	San Rafael94903	NCT06029270	Map
CA	Exelixis Clinical Site #59	Santa Barbara93463	NCT05176483	Map
CA	Sansum Clinic	Santa Barbara93105	NCT06246916	Map
CA	Kaiser Permanente Medical Center - Santa Clara	Santa Clara95051	NCT05987241	Map
CA	Kaiser Permanente Medical Center - Santa Clara	Santa Clara95051	NCT06029270	Map
CA	Saint John's Health Center - John Wayne Cancer Institute (JWCI)	Santa Monica90404	NCT06112314	Map
CA	St John's Cancer Institute	Santa Monica90404	NCT06246916	Map
CA	UCLA Hematology/Oncology - Santa Monica	Santa Monica90404	NCT06561386	Map
CA	Kaiser Permanente-Santa Rosa	Santa Rosa95403	NCT05987241	Map
CA	Kaiser Permanente-Santa Rosa	Santa Rosa95403	NCT06029270	Map
CA	Kaiser Permanente-South San Francisco	South San Francisco94080	NCT05987241	Map
CA	Kaiser Permanente-South San Francisco	South San Francisco94080	NCT06029270	Map
CA	Stanford	Stanford94305	NCT06624644	Map
CA	Stanford Cancer Center	Stanford94305	NCT06743126	Map
CA	Kaiser Permanente-Vallejo	Vallejo94589	NCT05987241	Map
CA	Kaiser Permanente-Vallejo	Vallejo94589	NCT06029270	Map
CA	Kaiser Permanente-Walnut Creek	Walnut Creek94596	NCT05987241	Map
CA	Kaiser Permanente-Walnut Creek	Walnut Creek94596	NCT06029270	Map
CA	Kaiser Permanente-Woodland Hills	Woodland Hills91367	NCT05987241	Map
CO	Rocky Mountain Regional VA Medical Center	Aurora80045	NCT06246916	Map
CO	UCHealth University of Colorado Hospital	Aurora80045	NCT05987241	Map
CO	University of Colorado Anschutz	Aurora80045	NCT06624644	Map
CO	University of Colorado Cancer Center	Aurora80045	NCT06246916	Map
CO	University of Colorado Hospital - Anschutz Cancer Pavilion	Aurora80045	NCT06264180	Map
CO	University of Colorado, Anschutz Medical Campus	Aurora80045	NCT06112314	Map
CO	University of Colorado, Anschutz Medical Campus	Aurora80045	NCT06743126	Map
CO	Kaiser Permanente-Franklin	Denver80205	NCT05987241	Map
CO	The Melanoma & Skin Cancer Institute	Denver80222	NCT06112314	Map
CO	University of Colorado	Denver80204	NCT06624644	Map
CO	The Melanoma and Skin Cancer Institute	Englewood80113	NCT06264180	Map
CO	The Melanoma And Skin Cancer Institute	Englewood80113	NCT06246916	Map
CO	Cancer Care and Hematology-Fort Collins	Fort Collins80528	NCT05987241	Map
CO	Poudre Valley Hospital	Fort Collins80524	NCT05987241	Map
CO	UCHealth Greeley Hospital	Greeley80631	NCT05987241	Map
CO	UCHealth Highlands Ranch Hospital	Highlands Ranch80129	NCT05987241	Map
CO	Kaiser Permanente-Rock Creek	Lafayette80026	NCT05987241	Map
CO	Exelixis Clinical Site #87	Littleton80124	NCT05176483	Map
CO	Kaiser Permanente-Lone Tree	Lone Tree80124	NCT05987241	Map
CO	UCHealth Lone Tree Health Center	Lone Tree80124	NCT05987241	Map
CO	Medical Center of the Rockies	Loveland80538	NCT05987241	Map
CT	Hartford HealthCare - Avon	Avon06001	NCT05987241	Map
CT	Hartford HealthCare - Saint Vincent's Medical Center	Bridgeport06606	NCT05987241	Map
CT	Smilow Cancer Hospital-Derby Care Center	Derby06418	NCT05987241	Map
CT	Hartford Healthcare - Fairfield	Fairfield06824	NCT05987241	Map
CT	Smilow Cancer Hospital Care Center-Fairfield	Fairfield06824	NCT05987241	Map
CT	Smilow Cancer Hospital Care Center at Glastonbury	Glastonbury06033	NCT05987241	Map
CT	Smilow Cancer Hospital Care Center at Greenwich	Greenwich06830	NCT05987241	Map
CT	Smilow Cancer Hospital Care Center - Guilford	Guilford06437	NCT05987241	Map
CT	Hartford Hospital	Hartford06102	NCT05987241	Map
CT	Smilow Cancer Hospital Care Center at Saint Francis	Hartford06105	NCT05987241	Map
CT	Hartford HealthCare - Manchester	Manchester06042	NCT05987241	Map
CT	Midstate Medical Center	Meriden06451	NCT05987241	Map
CT	The Hospital of Central Connecticut	New Britain06050	NCT05987241	Map
CT	Exelixis Clinical Site #62	New Haven06510	NCT05176483	Map
CT	Yale Cancer Center	New Haven06510	NCT06246916	Map
CT	Yale Cancer Center	New Haven06510	NCT06743126	Map
CT	Yale University	New Haven06520	NCT05987241	Map
CT	Yale University	New Haven06510	NCT06963905	Map
CT	Yale-New Haven Hospital North Haven Medical Center	North Haven06473	NCT05987241	Map
CT	Smilow Cancer Hospital Care Center at Long Ridge	Stamford06902	NCT05987241	Map
CT	Smilow Cancer Hospital-Torrington Care Center	Torrington06790	NCT05987241	Map
CT	Smilow Cancer Hospital Care Center-Trumbull	Trumbull06611	NCT05987241	Map
CT	Smilow Cancer Hospital-Waterbury Care Center	Waterbury06708	NCT05987241	Map
CT	Smilow Cancer Hospital Care Center - Waterford	Waterford06385	NCT05987241	Map
DE	Helen F Graham Cancer Center	Newark19713	NCT05987241	Map
DE	Medical Oncology Hematology Consultants PA	Newark19713	NCT05987241	Map
DC	George Washington University Medical Center	Washington D.C.20037	NCT05987241	Map
DC	Georgetown University	Washington D.C.20007	NCT06112314	Map
DC	MedStar Georgetown University Hospital	Washington D.C.20007	NCT05987241	Map
DC	MedStar Washington Hospital Center	Washington D.C.20010	NCT05987241	Map
DC	MedStar Washington Hospital Center	Washington D.C.20010	NCT06264180	Map
DC	Sibley Memorial Hospital	Washington D.C.20016	NCT05987241	Map
FL	Mount Sinai Comprehensive Cancer Center at Aventura	Aventura33180	NCT05987241	Map
FL	Exelixis Clinical Site #48	Celebration34747	NCT05176483	Map
FL	Clermont Oncology Center	Clermont34711	NCT06246916	Map
FL	UM Sylvester Comprehensive Cancer Center at Coral Gables	Coral Gables33146	NCT05987241	Map
FL	UM Sylvester Comprehensive Cancer Center at Deerfield Beach	Deerfield Beach33442	NCT05987241	Map
FL	Exelixis Clinical Site #11	Gainesville32610	NCT05176483	Map
FL	Malcom Randall Veterans Administration Medical Center	Gainesville32610	NCT05987241	Map
FL	UF Health Cancer Institute - Gainesville	Gainesville32610	NCT05987241	Map
FL	Memorial Cancer Institute at Memorial Regional Hospital	Hollywood33021	NCT06264180	Map
FL	Memorial Regional Hospital/Joe DiMaggio Children's Hospital	Hollywood33021	NCT05987241	Map
FL	Baptist MD Anderson Cancer Center	Jacksonville32207	NCT06264180	Map
FL	Cancer Specialist of North Florida	Jacksonville32256	NCT06246916	Map
FL	Exelixis Clinical Site #78	Jacksonville32224	NCT05176483	Map
FL	Mayo Clinic Florida	Jacksonville32224	NCT06112314	Map
FL	Mayo Clinic Florida	Jacksonville32224	NCT06246916	Map
FL	Exelixis Clinical Site #47	Miami33136	NCT05176483	Map
FL	Miami Cancer Institute	Miami33176	NCT05987241	Map
FL	UM Sylvester Comprehensive Cancer Center at Kendall	Miami33176	NCT05987241	Map
FL	University of Miami - Sylvester Comprehensive Cancer Cente	Miami33136	NCT06743126	Map
FL	University of Miami Health System-Sylvester Comprehensive Cancer Center-Miami	Miami33136	NCT06112314	Map
FL	University of Miami Hospital and Clinics, Sylvester Cancer Center	Miami33136	NCT06561386	Map
FL	University of Miami Miller School of Medicine-Sylvester Cancer Center	Miami33136	NCT05987241	Map
FL	University of Miami Sylvester Comprehensive Cancer Center at Sole Mia	North Miami33181	NCT05987241	Map
FL	AdventHealth Orlando	Orlando32803	NCT05987241	Map
FL	Memorial Hospital West	Pembroke Pines33028	NCT05987241	Map
FL	Memorial Hospital West	Pembroke Pines33028	NCT06561386	Map
FL	Exelixis Clinical Site #61	Plantation33322	NCT05176483	Map
FL	UM Sylvester Comprehensive Cancer Center at Plantation	Plantation33324	NCT05987241	Map
FL	Florida Cancer Specialists - North	St. Petersburg33705	NCT06561386	Map
FL	Boca Raton Clinical Research (BRCR) Global	Tamarac33321	NCT06246916	Map
FL	Exelixis Clinical Site #8	Tampa33612	NCT05176483	Map
FL	H. Lee Moffitt Cancer Center	Tampa33612	NCT06246916	Map
FL	Moffitt Cancer Center	Tampa33612	NCT06264180	Map
FL	Moffitt Cancer Center	Tampa33612	NCT06295159	Map
FL	Moffitt Cancer Center	Tampa87535	NCT06624644	Map
FL	Moffitt Cancer Center	Tampa33612	NCT06743126	Map
FL	Florida Cancer Specialists - East	West Palm Beach33401	NCT06561386	Map
GA	University Cancer & Blood Center	Athens30607	NCT06246916	Map
GA	Emory Saint Joseph's Hospital	Atlanta30342	NCT05987241	Map
GA	Emory University Hospital Midtown	Atlanta30308	NCT05987241	Map
GA	Emory University Hospital Midtown	Atlanta30308	NCT06029270	Map
GA	Emory University Hospital/Winship Cancer Institute	Atlanta30322	NCT05987241	Map
GA	Grady Health System	Atlanta30303	NCT05987241	Map
GA	Northside Hospital	Atlanta30342	NCT05987241	Map
GA	Winship Cancer Institute, Emory University	Atlanta30322	NCT06264180	Map
GA	Northside Hospital - Duluth	Duluth30096	NCT05987241	Map
GA	Emory Johns Creek Hospital	Johns Creek30097	NCT05987241	Map
GA	Northside Hospital - Gwinnett	Lawrenceville30046	NCT05987241	Map
HI	Kaiser Permanente Moanalua Medical Center	Honolulu96819	NCT05987241	Map
HI	Kaiser Permanente Moanalua Medical Center	Honolulu96819	NCT06029270	Map
ID	Saint Alphonsus Cancer Care Center-Boise	Boise83706	NCT05987241	Map
ID	Saint Alphonsus Cancer Care Center-Caldwell	Caldwell83605	NCT05987241	Map
ID	Beacon Clinic	Coeur d'Alene83815	NCT06246916	Map
ID	Kootenai Health - Coeur d'Alene	Coeur d'Alene83814	NCT05987241	Map
ID	Kootenai Health - Coeur d'Alene	Coeur d'Alene83814	NCT06029270	Map
ID	Saint Alphonsus Cancer Care Center-Nampa	Nampa83687	NCT05987241	Map
ID	Kootenai Clinic Cancer Services - Post Falls	Post Falls83854	NCT05987241	Map
ID	Kootenai Clinic Cancer Services - Post Falls	Post Falls83854	NCT06029270	Map
ID	Kootenai Clinic Cancer Services - Sandpoint	Sandpoint83864	NCT05987241	Map
ID	Kootenai Clinic Cancer Services - Sandpoint	Sandpoint83864	NCT06029270	Map
IL	Advocate Good Shepherd Hospital	Barrington60010	NCT05987241	Map
IL	Illinois CancerCare-Bloomington	Bloomington61704	NCT05987241	Map
IL	Illinois CancerCare-Canton	Canton61520	NCT05987241	Map
IL	Illinois CancerCare-Carthage	Carthage62321	NCT05987241	Map
IL	Advocate Illinois Masonic Medical Center	Chicago60657	NCT05987241	Map
IL	Exelixis Clinical Site #26	Chicago60612	NCT05176483	Map
IL	Northwestern Memorial Hospital	Chicago60611	NCT06264180	Map
IL	Northwestern University	Chicago60611	NCT05987241	Map
IL	Northwestern University	Chicago60611	NCT06029270	Map
IL	Northwestern University - Robert H. Lurie Comprehensive Cancer Center - NMDTI	Chicago60611	NCT06112314	Map
IL	Swedish Covenant Hospital	Chicago60625	NCT05987241	Map
IL	University of Chicago Comprehensive Cancer Center	Chicago60637	NCT05987241	Map
IL	University of Chicago Medical Center	Chicago60637	NCT06743126	Map
IL	University of Illinois	Chicago60612	NCT05987241	Map
IL	University of Illinois	Chicago60612	NCT06029270	Map
IL	Affiliated Oncologists, LLC	Chicago Ridge60415	NCT06561386	Map
IL	AMG Crystal Lake - Oncology	Crystal Lake60014	NCT05987241	Map
IL	Carle at The Riverfront	Danville61832	NCT05987241	Map
IL	Carle at The Riverfront	Danville61832	NCT06029270	Map
IL	Cancer Care Specialists of Illinois - Decatur	Decatur62526	NCT05987241	Map
IL	Decatur Memorial Hospital	Decatur62526	NCT05987241	Map
IL	Northwestern Medicine Cancer Center Kishwaukee	DeKalb60115	NCT05987241	Map
IL	Northwestern Medicine Cancer Center Kishwaukee	DeKalb60115	NCT06029270	Map
IL	Illinois CancerCare-Dixon	Dixon61021	NCT05987241	Map
IL	Advocate Good Samaritan Hospital	Downers Grove60515	NCT05987241	Map
IL	Carle Physician Group-Effingham	Effingham62401	NCT05987241	Map
IL	Carle Physician Group-Effingham	Effingham62401	NCT06029270	Map
IL	Crossroads Cancer Center	Effingham62401	NCT05987241	Map
IL	Advocate Sherman Hospital	Elgin60123	NCT05987241	Map
IL	Illinois CancerCare-Eureka	Eureka61530	NCT05987241	Map
IL	NorthShore University HealthSystem-Evanston Hospital	Evanston60201	NCT05987241	Map
IL	Illinois CancerCare-Galesburg	Galesburg61401	NCT05987241	Map
IL	Northwestern Medicine Cancer Center Delnor	Geneva60134	NCT05987241	Map
IL	Northwestern Medicine Cancer Center Delnor	Geneva60134	NCT06029270	Map
IL	NorthShore University HealthSystem-Glenbrook Hospital	Glenview60026	NCT05987241	Map
IL	Northwestern Medicine Glenview Outpatient Center	Glenview60026	NCT05987241	Map
IL	Northwestern Medicine Glenview Outpatient Center	Glenview60026	NCT06029270	Map
IL	Northwestern Medicine Grayslake Outpatient Center	Grayslake60030	NCT05987241	Map
IL	Northwestern Medicine Grayslake Outpatient Center	Grayslake60030	NCT06029270	Map
IL	Ingalls Memorial Hospital	Harvey60426	NCT05987241	Map
IL	Advocate South Suburban Hospital	Hazel Crest60429	NCT05987241	Map
IL	NorthShore University HealthSystem-Highland Park Hospital	Highland Park60035	NCT05987241	Map
IL	Hope and Healing Cancer Services	Hinsdale60521	NCT06246916	Map
IL	Illinois CancerCare-Kewanee Clinic	Kewanee61443	NCT05987241	Map
IL	Northwestern Medicine Lake Forest Hospital	Lake Forest60045	NCT05987241	Map
IL	Northwestern Medicine Lake Forest Hospital	Lake Forest60045	NCT06029270	Map
IL	AMG Libertyville - Oncology	Libertyville60048	NCT05987241	Map
IL	Condell Memorial Hospital	Libertyville60048	NCT05987241	Map
IL	Illinois CancerCare-Macomb	Macomb61455	NCT05987241	Map
IL	Carle Physician Group-Mattoon/Charleston	Mattoon61938	NCT05987241	Map
IL	Carle Physician Group-Mattoon/Charleston	Mattoon61938	NCT06029270	Map
IL	UC Comprehensive Cancer Center at Silver Cross	New Lenox60451	NCT05987241	Map
IL	Cancer Care Center of O'Fallon	O'Fallon62269	NCT05987241	Map
IL	Northwestern Medicine Oak Brook	Oak Brook60523	NCT05987241	Map
IL	Advocate Christ Medical Center	Oak Lawn60453-2699	NCT05987241	Map
IL	Northwestern Medicine Orland Park	Orland Park60462	NCT05987241	Map
IL	Northwestern Medicine Orland Park	Orland Park60462	NCT06029270	Map
IL	University of Chicago Medicine-Orland Park	Orland Park60462	NCT05987241	Map
IL	Illinois CancerCare-Ottawa Clinic	Ottawa61350	NCT05987241	Map
IL	Advocate Lutheran General Hospital	Park Ridge60068	NCT05987241	Map
IL	Advocate Lutheran General Hospital	Park Ridge60068	NCT06246916	Map
IL	Illinois CancerCare-Pekin	Pekin61554	NCT05987241	Map
IL	Illinois CancerCare	Peoria61615	NCT06246916	Map
IL	Illinois CancerCare-Peoria	Peoria61615	NCT05987241	Map
IL	Illinois CancerCare-Peru	Peru61354	NCT05987241	Map
IL	Illinois CancerCare-Princeton	Princeton61356	NCT05987241	Map
IL	UW Health Carbone Cancer Center Rockford	Rockford61114	NCT05987241	Map
IL	Memorial Hospital East	Shiloh62269	NCT05987241	Map
IL	Southern Illinois University School of Medicine	Springfield62702	NCT05987241	Map
IL	Springfield Clinic	Springfield62702	NCT05987241	Map
IL	Springfield Memorial Hospital	Springfield62781	NCT05987241	Map
IL	Carle Cancer Center	Urbana61801	NCT05987241	Map
IL	Carle Cancer Center	Urbana61801	NCT06029270	Map
IL	Northwestern Medicine Cancer Center Warrenville	Warrenville60555	NCT05987241	Map
IL	Northwestern Medicine Cancer Center Warrenville	Warrenville60555	NCT06029270	Map
IL	Illinois CancerCare - Washington	Washington61571	NCT05987241	Map
IN	UChicago Medicine Northwest Indiana	Crown Point46307	NCT05987241	Map
IN	Fort Wayne Medical Oncology and Hematology	Fort Wayne46825	NCT06246916	Map
IN	Exelixis Clinical Site #4	Indianapolis46250	NCT05176483	Map
IN	Indiana University/Melvin and Bren Simon Cancer Center	Indianapolis46202	NCT05987241	Map
IA	Mary Greeley Medical Center	Ames50010	NCT05987241	Map
IA	McFarland Clinic - Ames	Ames50010	NCT05987241	Map
IA	UI Health Care Mission Cancer and Blood - Ankeny Clinic	Ankeny50023	NCT05987241	Map
IA	UI Health Care Mission Cancer and Blood - Ankeny Clinic	Ankeny50023	NCT06029270	Map
IA	Saint Anthony Regional Hospital	Carroll51401	NCT06029270	Map
IA	UI Health Care Mission Cancer and Blood - West Des Moines Clinic	Clive50325	NCT05987241	Map
IA	UI Health Care Mission Cancer and Blood - West Des Moines Clinic	Clive50325	NCT06029270	Map
IA	Methodist Jennie Edmundson Hospital	Council Bluffs51503	NCT06029270	Map
IA	Nebraska Cancer Specialists/Oncology Hematology West PC - MEJ	Council Bluffs51503	NCT06029270	Map
IA	Broadlawns Medical Center	Des Moines50314	NCT06029270	Map
IA	Iowa Methodist Medical Center	Des Moines50309	NCT05987241	Map
IA	Iowa Methodist Medical Center	Des Moines50309	NCT06029270	Map
IA	Mercy Medical Center - Des Moines	Des Moines50314	NCT05987241	Map
IA	Mercy Medical Center - Des Moines	Des Moines50314	NCT06029270	Map
IA	UI Health Care Mission Cancer and Blood - Des Moines Clinic	Des Moines50309	NCT05987241	Map
IA	UI Health Care Mission Cancer and Blood - Des Moines Clinic	Des Moines50309	NCT06029270	Map
IA	UI Health Care Mission Cancer and Blood - Laurel Clinic	Des Moines50314	NCT05987241	Map
IA	UI Health Care Mission Cancer and Blood - Laurel Clinic	Des Moines50314	NCT06029270	Map
IA	McFarland Clinic - Trinity Cancer Center	Fort Dodge50501	NCT05987241	Map
IA	UI Healthcare Mission Cancer and Blood - Fort Dodge	Fort Dodge50501	NCT06029270	Map
IA	University of Iowa	Iowa City52242	NCT06264180	Map
IA	University of Iowa/Holden Comprehensive Cancer Center	Iowa City52242	NCT05987241	Map
IA	McFarland Clinic - Marshalltown	Marshalltown50158	NCT05987241	Map
IA	UI Health Care Mission Cancer and Blood - Waukee Clinic	Waukee50263	NCT05987241	Map
IA	UI Health Care Mission Cancer and Blood - Waukee Clinic	Waukee50263	NCT06029270	Map
KS	HaysMed	Hays67601	NCT05987241	Map
KS	University of Kansas Cancer Center	Kansas City66160	NCT05987241	Map
KS	Lawrence Memorial Hospital	Lawrence66044	NCT05987241	Map
KS	The University of Kansas Cancer Center - Olathe	Olathe66061	NCT05987241	Map
KS	University of Kansas Cancer Center-Overland Park	Overland Park66210	NCT05987241	Map
KS	Salina Regional Health Center	Salina67401	NCT05987241	Map
KS	University of Kansas Health System Saint Francis Campus	Topeka66606	NCT05987241	Map
KS	The University of Kansas Cancer Center	Westwood66205	NCT06246916	Map
KS	The University of Kansas Cancer Center (KUCC) - Westwood	Westwood66205	NCT06112314	Map
KS	University of Kansas Cancer Center	Westwood66205	NCT06264180	Map
KS	University of Kansas Hospital-Westwood Cancer Center	Westwood66205	NCT05987241	Map
KS	Cancer Center of Kansas	Wichita67214	NCT06561386	Map
KY	Saint Elizabeth Medical Center Edgewood	Edgewood41017	NCT06561386	Map
KY	St. Elizabeth Healthcare - Edgewood	Edgewood41017	NCT06112314	Map
KY	Baptist Health Lexington	Lexington40503	NCT06561386	Map
KY	Markey Cancer Center Clinical Research Organization	Lexington40536	NCT06246916	Map
KY	University of Kentucky/Markey Cancer Center	Lexington40536	NCT05987241	Map
KY	Exelixis Clinical Site #122	Louisville40202	NCT05176483	Map
KY	The James Graham Brown Cancer Center at University of Louisville	Louisville40202	NCT05987241	Map
KY	University of Louisville Brown Cancer Center	Louisville40202	NCT06264180	Map
KY	University of Louisville-James Graham Brown Cancer Center	Louisville40202	NCT03899155	Map
KY	UofL Health Medical Center Northeast	Louisville40245	NCT05987241	Map
LA	Louisiana Hematology Oncology Associates LLC	Baton Rouge70809	NCT05987241	Map
LA	Mary Bird Perkins Cancer Center	Baton Rouge70809	NCT06246916	Map
LA	Mary Bird Perkins Cancer Center - Metairie	Metairie70002	NCT05987241	Map
LA	Ochsner Medical Center Jefferson	New Orleans70121	NCT05987241	Map
ME	Lafayette Family Cancer Center-EMMC	Brewer04412	NCT05987241	Map
MD	Exelixis Clinical Site #14	Baltimore21201	NCT05176483	Map
MD	Johns Hopkins Hospital	Baltimore21231	NCT03521830	Map
MD	Johns Hopkins University/Sidney Kimmel Cancer Center	Baltimore21287	NCT05987241	Map
MD	University of Maryland/Greenebaum Cancer Center	Baltimore21201	NCT05987241	Map
MD	University of MD Greenebaum Comprehensive Cancer Center	Baltimore21201	NCT06743126	Map
MD	Maryland Oncology Hematology, P.A.	Columbia21044	NCT06246916	Map
MD	UPMC Western Maryland	Cumberland21502	NCT05987241	Map
MD	FMH James M Stockman Cancer Institute	Frederick21702	NCT05987241	Map
MA	Beverly Hospital	Beverly01915	NCT05987241	Map
MA	Beth Israel Deaconess Medical Center	Boston02215	NCT05987241	Map
MA	Beth Israel Deaconess Medical Center	Boston02215	NCT06708949	Map
MA	Beth Israel Deaconess Medical Center	Boston02215	NCT06743126	Map
MA	Dana Farber	Boston02215	NCT06624644	Map
MA	Dana Farber Cancer Institute	Boston02215	NCT05428007	Map
MA	Dana Farber Cancer Institute	Boston02215	NCT06112314	Map
MA	Dana_Farber Cancer Institute (DFCI)	Boston02215	NCT03899155	Map
MA	Dana-Farber Cancer Institute	Boston02215	NCT05987241	Map
MA	Exelixis Clinical Site #7	Boston02215	NCT05176483	Map
MA	Massachusetts General Hospital	Boston02114	NCT05428007	Map
MA	Massachusetts General Hospital	Boston02114	NCT06112314	Map
MA	Massachusetts General Hospital	Boston02114	NCT06743126	Map
MA	Dana-Farber Cancer Institute at Boston Medical Center - Brighton	Brighton02135	NCT05987241	Map
MA	Lahey Hospital and Medical Center	Burlington01805	NCT05987241	Map
MA	Dana-Farber Cancer Institute at Foxborough	Foxborough02035	NCT05987241	Map
MA	Addison Gilbert Hospital	Gloucester01930	NCT05987241	Map
MA	Dana-Farber/Brigham and Women's Cancer Center at Milford Regional	Milford01757	NCT05987241	Map
MA	Lahey Medical Center-Peabody	Peabody01960	NCT05987241	Map
MA	Dana-Farber/Brigham and Women's Cancer Center at South Shore	South Weymouth02190	NCT05987241	Map
MI	Trinity Health Saint Joseph Mercy Hospital Ann Arbor	Ann Arbor48106	NCT05987241	Map
MI	University of Michigan	Ann Arbor48109	NCT06246916	Map
MI	University of Michigan	Ann Arbor48109	NCT06743126	Map
MI	University of Michigan Rogel Cancer Center	Ann Arbor48109	NCT05987241	Map
MI	Bronson Battle Creek	Battle Creek49017	NCT05987241	Map
MI	McLaren Cancer Institute-Bay City	Bay City48706	NCT05987241	Map
MI	Trinity Health IHA Medical Group Hematology Oncology - Brighton	Brighton48114	NCT05987241	Map
MI	University of Michigan - Brighton Center for Specialty Care	Brighton48116	NCT05987241	Map
MI	Henry Ford Cancer Institute-Downriver	Brownstown48183	NCT05987241	—
MI	Trinity Health IHA Medical Group Hematology Oncology - Canton	Canton48188	NCT05987241	Map
MI	Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital	Chelsea48118	NCT05987241	Map
MI	Henry Ford Macomb Hospital-Clinton Township	Clinton Township48038	NCT05987241	Map
MI	Henry Ford Medical Center-Fairlane	Dearborn48126	NCT05987241	Map
MI	Exelixis Clinical Site #13	Detroit48202	NCT05176483	Map
MI	Exelixis Clinical Site #65	Detroit48201	NCT05176483	Map
MI	Henry Ford Cancer Center - Michigan	Detroit04820	NCT06112314	Map
MI	Henry Ford Cancer Institute/Henry Ford Health System	Detroit48202	NCT06246916	Map
MI	Henry Ford Hospital	Detroit48202	NCT05987241	Map
MI	Wayne State University/Karmanos Cancer Institute	Detroit48201	NCT05987241	Map
MI	OSF Saint Francis Hospital and Medical Group	Escanaba49829	NCT05987241	Map
MI	Weisberg Cancer Treatment Center	Farmington Hills48334	NCT05987241	Map
MI	Cancer Hematology Centers - Flint	Flint48503	NCT05987241	Map
MI	Genesys Hurley Cancer Institute	Flint48503	NCT05987241	Map
MI	Hurley Medical Center	Flint48503	NCT05987241	Map
MI	Corewell Health	Grand Rapids49503	NCT06264180	Map
MI	Corewell Health Grand Rapids Hospitals - Butterworth Hospital	Grand Rapids49503	NCT05987241	Map
MI	Trinity Health Grand Rapids Hospital	Grand Rapids49503	NCT05987241	Map
MI	Allegiance Health	Jackson49201	NCT05987241	Map
MI	Bronson Methodist Hospital	Kalamazoo49007	NCT05987241	Map
MI	West Michigan Cancer Center	Kalamazoo49007	NCT05987241	Map
MI	Karmanos Cancer Institute at McLaren Greater Lansing	Lansing48910	NCT05987241	Map
MI	University of Michigan Health - Sparrow Lansing	Lansing48912	NCT05987241	Map
MI	Trinity Health Saint Mary Mercy Livonia Hospital	Livonia48154	NCT05987241	Map
MI	Trinity Health Muskegon Hospital	Muskegon49444	NCT05987241	Map
MI	Corewell Health Lakeland Hospitals - Niles Hospital	Niles49120	NCT05987241	Map
MI	Cancer and Hematology Centers of Western Michigan - Norton Shores	Norton Shores49444	NCT05987241	Map
MI	Henry Ford Medical Center-Columbus	Novi48377	NCT05987241	Map
MI	McLaren Cancer Institute-Northern Michigan	Petoskey49770	NCT05987241	Map
MI	Trinity Health Saint Joseph Mercy Oakland Hospital	Pontiac48341	NCT05987241	Map
MI	Corewell Health Reed City Hospital	Reed City49677	NCT05987241	Map
MI	MyMichigan Medical Center Saginaw	Saginaw48601	NCT05987241	Map
MI	Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center	Saint Joseph49085	NCT05987241	Map
MI	Corewell Health Lakeland Hospitals - Saint Joseph Hospital	Saint Joseph49085	NCT05987241	Map
MI	MyMichigan Medical Center Tawas	Tawas City48764	NCT05987241	Map
MI	Munson Medical Center	Traverse City49684	NCT05987241	Map
MI	Henry Ford West Bloomfield Hospital	West Bloomfield48322	NCT05987241	Map
MI	Henry Ford Wyandotte Hospital	Wyandotte48192	NCT05987241	Map
MI	University of Michigan Health - West	Wyoming49519	NCT05987241	Map
MI	Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus	Ypsilanti48197	NCT05987241	Map
MN	Sanford Joe Lueken Cancer Center	Bemidji56601	NCT05987241	Map
MN	Mercy Hospital	Coon Rapids55433	NCT05987241	Map
MN	Fairview Southdale Hospital	Edina55435	NCT05987241	Map
MN	Minnesota Oncology Hematology, P.A	Fridley55432	NCT06246916	Map
MN	Abbott-Northwestern Hospital	Minneapolis55407	NCT05987241	Map
MN	Allina Health Cancer Institute	Minneapolis55407	NCT06246916	Map
MN	Allina Health Cancer Institute - Minneapolis	Minneapolis55407	NCT06112314	Map
MN	Hennepin County Medical Center	Minneapolis55415	NCT05987241	Map
MN	University of Minnesota	Minneapolis55455	NCT06264180	Map
MN	Exelixis Clinical Site #68	Rochester55905	NCT05176483	Map
MN	Coborn Cancer Center at Saint Cloud Hospital	Saint Cloud56303	NCT05987241	Map
MN	Park Nicollet Clinic - Saint Louis Park	Saint Louis Park55416	NCT05987241	Map
MN	Regions Hospital	Saint Paul55101	NCT05987241	Map
MN	United Hospital	Saint Paul55102	NCT05987241	Map
MS	Hattiesburg Clinic Hematology/Oncology	Hattiesburg39401-7233	NCT06561386	Map
MS	University of Mississippi Medical Center	Jackson39216	NCT05987241	Map
MO	Saint Francis Medical Center	Cape Girardeau63703	NCT05987241	Map
MO	Siteman Cancer Center at Saint Peters Hospital	City of Saint Peters63376	NCT05987241	Map
MO	MU Health - University Hospital/Ellis Fischel Cancer Center	Columbia65212	NCT05987241	Map
MO	Siteman Cancer Center at West County Hospital	Creve Coeur63141	NCT05987241	Map
MO	Parkland Health Center - Farmington	Farmington63640	NCT05987241	Map
MO	University Health Truman Medical Center	Kansas City64108	NCT05987241	Map
MO	University of Kansas Cancer Center - Briarcliff	Kansas City64116	NCT05987241	Map
MO	University of Kansas Cancer Center - North	Kansas City64154	NCT05987241	Map
MO	University of Kansas Cancer Center - Lee's Summit	Lee's Summit64064	NCT05987241	Map
MO	Sainte Genevieve County Memorial Hospital	Sainte Genevieve63670	NCT05987241	Map
MO	Mercy Hospital Springfield	Springfield65804	NCT05987241	Map
MO	Mercy Hospital Saint Louis	St Louis63141	NCT05987241	Map
MO	Mercy Hospital Saint Louis	St Louis63141	NCT06029270	Map
MO	Mercy Hospital South	St Louis63128	NCT05987241	Map
MO	Mercy Hospital South	St Louis63128	NCT06029270	Map
MO	Mercy South	St Louis63128	NCT06246916	Map
MO	Missouri Baptist Medical Center	St Louis63131	NCT05987241	Map
MO	Siteman Cancer Center at Christian Hospital	St Louis63136	NCT05987241	Map
MO	Siteman Cancer Center-South County	St Louis63129	NCT05987241	Map
MO	VA St. Louis Healthcare System	St Louis63106	NCT06246916	Map
MO	Veteran's Affairs Medical Center - Saint Louis	St Louis63125	NCT05987241	Map
MO	Washington University	St Louis63110	NCT06246916	Map
MO	Washington University School of Medicine	St Louis63110	NCT05987241	Map
MO	Missouri Baptist Sullivan Hospital	Sullivan63080	NCT05987241	Map
MO	BJC Outpatient Center at Sunset Hills	Sunset Hills63127	NCT05987241	Map
MT	Community Hospital of Anaconda	Anaconda59711	NCT05987241	Map
MT	Community Hospital of Anaconda	Anaconda59711	NCT06029270	Map
MT	Billings Clinic Cancer Center	Billings59101	NCT05987241	Map
MT	Billings Clinic Cancer Center	Billings59101	NCT06029270	Map
MT	St. Vincent Healthcare	Billings59102	NCT06246916	Map
MT	Bozeman Health Deaconess Hospital	Bozeman59715	NCT05987241	Map
MT	Bozeman Health Deaconess Hospital	Bozeman59715	NCT06029270	Map
MT	Benefis Sletten Cancer Institute	Great Falls59405	NCT05987241	Map
MT	Benefis Sletten Cancer Institute	Great Falls59405	NCT06029270	Map
MT	Logan Health Medical Center	Kalispell59901	NCT05987241	Map
MT	Logan Health Medical Center	Kalispell59901	NCT06029270	Map
MT	Community Medical Center	Missoula59804	NCT05987241	Map
MT	Community Medical Center	Missoula59804	NCT06029270	Map
NE	Nebraska Medicine-Bellevue	Bellevue68123	NCT05987241	Map
NE	Exelixis Clinical Site #2	Omaha68130	NCT05176483	Map
NE	Nebraska Cancer Specialists/Oncology Hematology West PC - MECC	Omaha68114	NCT06029270	Map
NE	Nebraska Medicine-Village Pointe	Omaha68118	NCT05987241	Map
NE	Nebraska Methodist Hospital	Omaha68114	NCT06029270	Map
NE	Oncology Hematology West P.C. dba Nebraska Cancer Specialists	Omaha68130	NCT06246916	Map
NE	University of Nebraska Medical Center	Omaha68198	NCT05987241	Map
NE	University of Nebraska Medical Center	Omaha68198	NCT06743126	Map
NV	Comprehensive Cancer Centers of Nevada	Las Vegas89148	NCT06246916	Map
NV	Exelixis Clinical Site #55	Las Vegas89052	NCT05176483	Map
NV	OptumCare Cancer Care at Charleston	Las Vegas89102	NCT05987241	Map
NV	OptumCare Cancer Care at Fort Apache	Las Vegas89183	NCT05987241	Map
NV	Renown Regional Medical Center	Reno89502	NCT06561386	Map
NH	Dartmouth Hitchcock Cancer Center	Lebanon03756	NCT06264180	Map
NH	Dartmouth Hitchcock Medical Center	Lebanon03756	NCT06246916	Map
NJ	Memorial Sloan Kettering Basking Ridge	Basking Ridge07920	NCT05987241	Map
NJ	Jefferson Cherry Hill Hospital	Cherry Hill08002	NCT05987241	Map
NJ	Exelixis Clinical Site #88	East Brunswick08816	NCT05176483	Map
NJ	Exelixis Clinical Site #105	Hackensack07601	NCT05176483	Map
NJ	Hackensack University Medical Center	Hackensack07601	NCT05987241	Map
NJ	Hackensack University Medical Center	Hackensack07601	NCT06264180	Map
NJ	John Theurer Cancer Center	Hackensack07601	NCT06246916	Map
NJ	John Theurer Cancer Center at Hackensack University Medical Center	Hackensack07601	NCT06112314	Map
NJ	John Theurer Cancer Center at Hackensack University Medical Center	Hackensack07601	NCT06697197	Map
NJ	Jersey City Medical Center	Jersey City07302	NCT05987241	Map
NJ	Monmouth Medical Center Southern Campus	Lakewood08701	NCT05987241	Map
NJ	Saint Barnabas Medical Center	Livingston07039	NCT05987241	Map
NJ	Monmouth Medical Center	Long Branch07740	NCT05987241	Map
NJ	Southern Ocean County Medical Center	Manahawkin08050	NCT05987241	Map
NJ	Memorial Sloan Kettering Monmouth	Middletown07748	NCT05987241	Map
NJ	Memorial Sloan Kettering Bergen	Montvale07645	NCT05987241	Map
NJ	Atlantic Health System/Morristown Medical Center	Morristown07960	NCT06743126	Map
NJ	Morristown Medical Center - Atlantic Health System	Morristown07960	NCT06264180	Map
NJ	Rutgers Cancer Institute of New Jersey	New Brunswick08903	NCT05987241	Map
NJ	Rutgers Cancer Institute of New Jersey	New Brunswick08901	NCT06246916	Map
NJ	The Valley Hospital Inc.	Paramus07652	NCT06246916	Map
NJ	Sidney Kimmel Cancer Center Washington Township	Sewell08080	NCT05987241	Map
NJ	Robert Wood Johnson University Hospital Somerset	Somerville08876	NCT05987241	Map
NJ	Community Medical Center	Toms River08755	NCT05987241	Map
NM	Presbyterian Kaseman Hospital	Albuquerque87110	NCT05987241	Map
NM	University of New Mexico	Albuquerque87106	NCT06624644	Map
NM	Presbyterian Rust Medical Center/Jorgensen Cancer Center	Rio Rancho87124	NCT05987241	Map
NY	New York Oncology Hematology	Albany12206	NCT06246916	Map
NY	Maimonides Medical Center	Brooklyn11219	NCT05987241	Map
NY	Roswell Park Cancer Institute	Buffalo14263	NCT03899155	Map
NY	Roswell Park Cancer Institute	Buffalo14263	NCT06264180	Map
NY	Memorial Sloan Kettering Commack	Commack11725	NCT05987241	Map
NY	The New York Hospital Medical Center of Queens	Flushing11355	NCT05987241	Map
NY	Glens Falls Hospital	Glens Falls12801	NCT05987241	Map
NY	Memorial Sloan Kettering Westchester	Harrison10604	NCT05987241	Map
NY	Northwell Health Cancer Institute	Lake Success11042	NCT06112314	Map
NY	Northwell Health, R.J. Zuckerberg Cancer Center	Lake Success11042	NCT06264180	Map
NY	Northwell Health/ RJ Zuckerberg Cancer Center	Lake Success11042	NCT06697197	Map
NY	NYU Langone Hematology Oncology Associates-Mineola	Mineola11501	NCT03899155	Map
NY	Exelixis Clinical Site #6	New York10065	NCT05176483	Map
NY	Exelixis Clinical Site #60	New York10032	NCT05176483	Map
NY	Laura and Isaac Perlmutter Cancer Center at NYU Langone Health	New York10016	NCT06743126	Map
NY	Memorial Sloan Kettering Cancer Center	New York10065	NCT05987241	Map
NY	Memorial Sloan Kettering Cancer Center	New York10065	NCT06743126	Map
NY	Mount Sinai Chelsea	New York10011	NCT05987241	Map
NY	Mount Sinai Hospital	New York10029	NCT05987241	Map
NY	NYP/Weill Cornell Medical Center	New York10065	NCT05987241	Map
NY	NYU Langone Health	New York10016	NCT05428007	Map
NY	NYU Langone Health	New York10016	NCT07504796	Map
NY	Veterans Affairs New York Harbor Healthcare System	New York10016	NCT06561386	Map
NY	Rochester General Hospital	Rochester14621	NCT05987241	Map
NY	Unity Park Ridge Campus	Rochester14626	NCT05987241	Map
NY	University of Rochester	Rochester14642	NCT05987241	Map
NY	University of Rochester	Rochester14642	NCT06743126	Map
NY	University of Rochester Medical Center	Rochester14642	NCT06561386	Map
NY	Stony Brook University Medical Center	Stony Brook11794	NCT05987241	Map
NY	Exelixis Clinical Site #76	Syracuse13210	NCT05176483	Map
NY	SUNY Upstate Medical University	Syracuse13210	NCT06561386	Map
NY	Montefiore Medical Center	The Bronx10461	NCT06264180	Map
NY	Montefiore Medical Center-Einstein Campus	The Bronx10461	NCT05987241	Map
NY	Memorial Sloan Kettering Nassau	Uniondale11553	NCT05987241	Map
NY	Wilmot Cancer Institute at Webster	Webster14580	NCT05987241	Map
NC	Atrium Health Stanly/LCI-Albemarle	Albemarle28002	NCT05987241	Map
NC	Messino Cancer Center	Asheville28806	NCT06246916	Map
NC	Duke Cancer Center Cary	Cary27518	NCT05987241	Map
NC	UNC Hospitals, The University of North Carolina at Chapel Hill	Chapel Hill27599	NCT06743126	Map
NC	UNC Lineberger Comprehensive Cancer Center	Chapel Hill27599	NCT05987241	Map
NC	University of North Carolina at Chapel Hill	Chapel Hill27514	NCT06264180	Map
NC	Atrium Health Pineville/LCI-Pineville	Charlotte28210	NCT05987241	Map
NC	Atrium Health University City/LCI-University	Charlotte28262	NCT05987241	Map
NC	Carolinas Medical Center/Levine Cancer Institute	Charlotte28203	NCT05987241	Map
NC	Levine Cancer Institute	Charlotte28204	NCT06246916	Map
NC	Levine Cancer Institute	Charlotte28204	NCT06697197	Map
NC	Levine Cancer Institute-Ballantyne	Charlotte28277	NCT05987241	Map
NC	Levine Cancer Institute-SouthPark	Charlotte28211	NCT05987241	Map
NC	Novant Health Cancer Institute	Charlotte28204	NCT06246916	Map
NC	Novant Health Weisiger Cancer Institute - Charlotte	Charlotte28204	NCT06246916	Map
NC	Wake Forest University at Clemmons	Clemmons27012	NCT05987241	Map
NC	Duke Cancer Center	Durham27710	NCT06264180	Map
NC	Duke Cancer Center Southpoint	Durham27713	NCT05987241	Map
NC	Duke Health System	Durham27710	NCT06246916	Map
NC	Duke University	Durham27750	NCT06816927	Map
NC	Duke University Medical Center	Durham27710	NCT05987241	Map
NC	Duke University Medical Center	Durham27710	NCT06708949	Map
NC	Exelixis Clinical Site #12	Durham27710	NCT05176483	Map
NC	Levine Cancer Institute - Rutherford	Forest City28043	NCT05987241	Map
NC	Levine Cancer Institute-Gaston	Gastonia28054	NCT05987241	Map
NC	East Carolina University	Greenville27858	NCT06561386	Map
NC	Levine Cancer Institute - Huntersville	Huntersville28078	NCT05987241	Map
NC	Atrium Health Lincoln/LCI-Lincolnton	Lincolnton28092	NCT05987241	Map
NC	Levine Cancer Institute - Union West	Matthews28104	NCT05987241	Map
NC	Atrium Health Union/LCI-Union	Monroe28112	NCT05987241	Map
NC	FirstHealth of the Carolinas-Moore Regional Hospital	Pinehurst28374	NCT05987241	Map
NC	Duke Cancer Center Raleigh	Raleigh27609	NCT05987241	Map
NC	Atrium Health Cleveland/LCI-Cleveland	Shelby28150	NCT05987241	Map
NC	Novant Health Zimmer Cancer Institute - Wilmington	Wilmington28401	NCT06246916	Map
NC	Wake Forest University Health Sciences	Winston-Salem27157	NCT05987241	Map
ND	Sanford Bismarck Medical Center	Bismarck58501	NCT05987241	Map
ND	Sanford Broadway Medical Center	Fargo58122	NCT05987241	Map
ND	Sanford Roger Maris Cancer Center	Fargo58122	NCT05987241	Map
OH	Oncology Hematology Care	Cincinnati45242	NCT03899155	Map
OH	Oncology Hematology Care Clinical Trials	Cincinnati45242	NCT06246916	Map
OH	University of Cincinnati Cancer Center-UC Medical Center	Cincinnati45219	NCT05987241	Map
OH	University of Cincinnati Medical Center	Cincinnati45219	NCT06561386	Map
OH	Cleveland Clinic, Taussig Cancer Institute	Cleveland44195	NCT06743126	Map
OH	Exelixis Clinical Site #10	Cleveland44106	NCT05176483	Map
OH	Seidman Cancer Center	Cleveland44106	NCT06246916	Map
OH	Ohio State University	Columbus43210	NCT06743126	Map
OH	Ohio State University Comprehensive Cancer Center	Columbus43210	NCT04697576	Map
OH	Ohio State University Comprehensive Cancer Center	Columbus43210	NCT05987241	Map
OH	The Ohio State University	Columbus43210	NCT06112314	Map
OH	The Ohio State University Wexner Medical Center	Columbus43210	NCT06246916	Map
OH	The Ohio State University- Martha Morehouse Tower	Columbus43210	NCT06264180	Map
OH	The Ohio University	Columbus43210	NCT03899155	Map
OH	ProMedica Flower Hospital	Sylvania43560	NCT05987241	Map
OH	University of Cincinnati Cancer Center-West Chester	West Chester45069	NCT05987241	Map
OK	Cancer Centers of Southwest Oklahoma Research	Lawton73505	NCT05987241	Map
OK	University of Oklahoma Health Sciences Center	Oklahoma City73104	NCT05987241	Map
OK	University of Oklahoma Health Sciences Center	Oklahoma City73104	NCT06029270	Map
OK	Oklahoma Cancer Specialists and Research Institute, LLC	Tulsa74146	NCT06246916	Map
OR	Oncology Associates of Oregon PC	Eugene97401	NCT06246916	Map
OR	Saint Alphonsus Cancer Care Center-Ontario	Ontario97914	NCT05987241	Map
OR	Providence Willamette Falls Medical Center	Oregon City97045	NCT05987241	Map
OR	Exelixis Clinical Site #51	Portland97239	NCT05176483	Map
OR	Kaiser Foundation Hospitals	Portland97227	NCT06246916	Map
OR	Oregon Health and Science University	Portland97239	NCT05987241	Map
OR	Oregon Health and Science University	Portland97239	NCT06246916	Map
OR	Providence Cancer Institute Franz Clinic	Portland97213	NCT06743126	Map
OR	Providence Portland Medical Center	Portland97213	NCT05987241	Map
OR	Providence Portland Medical Center	Portland97213	NCT06029270	Map
OR	Providence Saint Vincent Medical Center	Portland97225	NCT05987241	Map
OR	Providence Saint Vincent Medical Center	Portland97225	NCT06029270	Map
PA	Lehigh Valley Hospital-Cedar Crest	Allentown18103	NCT05987241	Map
PA	UPMC Altoona	Altoona16601	NCT05987241	Map
PA	UPMC-Heritage Valley Health System Beaver	Beaver15009	NCT05987241	Map
PA	Lehigh Valley Hospital - Muhlenberg	Bethlehem18017	NCT05987241	Map
PA	Pocono Medical Center	East Stroudsburg18301	NCT05987241	Map
PA	St. Luke's University Health Network	Easton18045	NCT06246916	Map
PA	UPMC Hillman Cancer Center Erie	Erie16505	NCT05987241	Map
PA	UPMC Cancer Centers - Arnold Palmer Pavilion	Greensburg15601	NCT05987241	Map
PA	UPMC Pinnacle Cancer Center/Community Osteopathic Campus	Harrisburg17109	NCT05987241	Map
PA	Exelixis Clinical Site #104	Hershey17033	NCT05176483	Map
PA	Lancaster General Health	Lancaster17601	NCT03899155	Map
PA	Lancaster General Hospital - Ann B Barshinger Cancer Institute	Lancaster17601	NCT06561386	Map
PA	UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion	Mechanicsburg17050	NCT05987241	Map
PA	UPMC Hillman Cancer Center - Monroeville	Monroeville15146	NCT05987241	Map
PA	Exelixis Clinical Site #98	Philadelphia19104	NCT05176483	Map
PA	Fox Chase Cancer Center	Philadelphia19111	NCT06246916	Map
PA	Fox Chase Cancer Center	Philadelphia19111	NCT06264180	Map
PA	Fox Chase Cancer Center	Philadelphia19111	NCT06743126	Map
PA	Jefferson Torresdale Hospital	Philadelphia19114	NCT05987241	Map
PA	Penn Medicine Abramson Cancer Center	Philadelphia19104	NCT06708949	Map
PA	Thomas Jeffersion University, Sidney Kimmel Cancer Center	Philadelphia19107	NCT06743126	Map
PA	Thomas Jefferson University	Philadelphia19107	NCT06112314	Map
PA	Thomas Jefferson University	Philadelphia19107	NCT06264180	Map
PA	Thomas Jefferson University Hospital	Philadelphia19107	NCT05987241	Map
PA	University of Pennsylvania, Abramson Cancer Center	Philadelphia19104	NCT06743126	Map
PA	UPenn	Philadelphia19107	NCT06624644	Map
PA	Exelixis Clinical Site #24	Pittsburgh15232	NCT05176483	Map
PA	Exelixis Clinical Site #32	Pittsburgh15212	NCT05176483	Map
PA	University of Pittsburgh Cancer Institute (UPCI)	Pittsburgh15232	NCT05987241	Map
PA	University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center	Pittsburgh15232	NCT06246916	Map
PA	UPMC	Pittsburgh15232	NCT06264180	Map
PA	UPMC Hillman Cancer Center	Pittsburgh15232	NCT06112314	Map
PA	UPMC Hillman Cancer Center	Pittsburgh15232	NCT06743126	Map
PA	UPMC Hillman Cancer Center	Pittsburgh15232	NCT07223411	Map
PA	UPMC-Passavant Hospital	Pittsburgh15237	NCT05987241	Map
PA	UPMC-Saint Clair Hospital Cancer Center	Pittsburgh15243	NCT05987241	Map
PA	UPMC-Saint Margaret	Pittsburgh15215	NCT05987241	Map
PA	Reading Hospital	West Reading19611	NCT05987241	Map
PA	Asplundh Cancer Pavilion	Willow Grove19090	NCT05987241	Map
RI	Lifespan Cancer Institute	Providence02903	NCT06246916	Map
RI	Rhode Island Hospital	Providence02903	NCT06264180	Map
RI	Smilow Cancer Hospital Care Center - Westerly	Westerly02891	NCT05987241	Map
SC	AnMed Health Cancer Center	Anderson29621	NCT05987241	Map
SC	Prisma Health Cancer Institute - Spartanburg	Boiling Springs29316	NCT05987241	Map
SC	Medical University of South Carolina	Charleston29425	NCT05987241	Map
SC	Medical University of South Carolina	Charleston29425	NCT06029270	Map
SC	Prisma Health Cancer Institute - Easley	Easley29640	NCT05987241	Map
SC	Gibbs Cancer Center-Gaffney	Gaffney29341	NCT05987241	Map
SC	Prisma Health Cancer Institute	Greenville29605	NCT06112314	Map
SC	Prisma Health Cancer Institute - Butternut	Greenville29605	NCT05987241	Map
SC	Prisma Health Cancer Institute - Eastside	Greenville29615	NCT05987241	Map
SC	Prisma Health Cancer Institute - Faris	Greenville29605	NCT05987241	Map
SC	Prisma Health Greenville Memorial Hospital	Greenville29605	NCT05987241	Map
SC	Gibbs Cancer Center-Pelham	Greer29651	NCT05987241	Map
SC	Prisma Health Cancer Institute - Greer	Greer29650	NCT05987241	Map
SC	Exelixis Clinical Site #9	Myrtle Beach29572	NCT05176483	Map
SC	Levine Cancer Institute-Rock Hill	Rock Hill29732	NCT05987241	Map
SC	Prisma Health Cancer Institute - Seneca	Seneca29672	NCT05987241	Map
SC	Spartanburg Medical Center	Spartanburg29303	NCT05987241	Map
SC	Spartanburg Regional Healthcare System - Spartanburg Medical Center (SMC)	Spartanburg29303	NCT06112314	Map
SC	SMC Center for Hematology Oncology Union	Union29379	NCT05987241	Map
SD	Avera Cancer Institute	Sioux Falls57105	NCT06743126	Map
SD	Sanford Cancer Center Oncology Clinic	Sioux Falls57104	NCT05987241	Map
SD	Sanford USD Medical Center - Sioux Falls	Sioux Falls57117-5134	NCT05987241	Map
TN	Tennessee Oncology - Chattanooga	Chattanooga37404	NCT06246916	Map
TN	West Cancer Center and Research Institute	Germantown38138	NCT06264180	Map
TN	The University of Tennessee - Knoxville (UTK)	Knoxville37920	NCT06112314	Map
TN	University of Tennessee	Knoxville37920	NCT06264180	Map
TN	University of Tennessee Medical Center	Knoxville37920	NCT06246916	Map
TN	Exelixis Clinical Site #3	Nashville37203	NCT05176483	Map
TN	Sarah Cannon Research Institute (SCRI) Oncology Partners	Nashville37203	NCT06246916	Map
TN	Sarah Cannon Research Institute: USA/TN	Nashville37203	NCT06112314	Map
TN	SCRI Oncology Partners	Nashville37203	NCT06743126	Map
TN	Tennesse Oncology	Nashville37203	NCT03899155	Map
TN	Tennessee Oncology	Nashville37203	NCT06246916	Map
TN	Tennessee Oncology, PLLC	Nashville37203	NCT06112314	Map
TN	Vanderbilt University Medical Center	Nashville37232	NCT06708949	Map
TN	Vanderbilt University/Ingram Cancer Center	Nashville37232	NCT05987241	Map
TX	Texas Oncology - West Texas	Abilene79606	NCT06561386	Map
TX	Exelixis Clinical Site #46	Austin78705	NCT05176483	Map
TX	Texas Oncology - Austin Central, Central Austin Cancer Center	Austin78731	NCT06246916	Map
TX	Texas Oncology - Austin Midtown, Midtown Medical Center I	Austin78705	NCT06246916	Map
TX	Texas Oncology - Bedford	Bedford76022	NCT06246916	Map
TX	Baylor University	Dallas75246	NCT06743126	Map
TX	Exelixis Clinical Site #111	Dallas75246	NCT05176483	Map
TX	Exelixis Clinical Site #89	Dallas75246	NCT05176483	Map
TX	Texas Oncology	Dallas75246	NCT06246916	Map
TX	Texas Oncology	Dallas75246	NCT06264180	Map
TX	Texas Oncology - Medical City	Dallas75230	NCT06246916	Map
TX	University of Texas Southwestern	Dallas75235-9179	NCT06112314	Map
TX	University of Texas Southwestern Medical Center	Dallas75390	NCT06264180	Map
TX	University of Texas Southwestern Medical Center	Dallas75390	NCT06708949	Map
TX	University of Texas Southwestern Medical Center	Dallas75390	NCT06743126	Map
TX	UT Southwestern Simmons Cancer Center - RedBird	Dallas75237	NCT05987241	Map
TX	UT Southwestern/Simmons Cancer Center-Dallas	Dallas75390	NCT05987241	Map
TX	Center For Disease And Blood Disorder	Fort Worth76104	NCT06246916	Map
TX	Texas Oncology - Fort Worth	Fort Worth76104	NCT06246916	Map
TX	UT Southwestern/Simmons Cancer Center-Fort Worth	Fort Worth76104	NCT05987241	Map
TX	Texas Oncology - Grapevine	Grapevine76051	NCT06246916	Map
TX	Texas Oncology - Harlingen, Medical Arts Pavillion	Harlingen78550	NCT06246916	Map
TX	Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center	Houston77030	NCT05987241	Map
TX	Ben Taub General Hospital	Houston77030	NCT05987241	Map
TX	Lyndon Baines Johnson General Hospital	Houston77026-1967	NCT05987241	Map
TX	M D Anderson Cancer Center	Houston77030	NCT05704647	Map
TX	Michael E DeBakey VA Medical Center	Houston77030	NCT05987241	Map
TX	The University of Texas M. D. Anderson Cancer Center	Houston77030	NCT06708949	Map
TX	The University of Texas MD Anderson Cancer Center	Houston77030	NCT06246916	Map
TX	The University of Texas MD Anderson Cancer Center	Houston77030	NCT06264180	Map
TX	The University of Texas MD Anderson Cancer Center	Houston77030	NCT06743126	Map
TX	University of Texas MD Anderson Cancer Center	Houston77030	NCT06561386	Map
TX	Exelixis Clinical Site #73	Irving75063	NCT05176483	Map
TX	Texas Oncology - Longview	Longview75601	NCT06246916	Map
TX	Joe Arrington Cancer Research & Treatment Center	Lubbock79410	NCT06246916	Map
TX	Texas Oncology - McAllen	McAllen78503	NCT06246916	Map
TX	Texas Oncology-Palestine Cancer Center	Palestine75801	NCT06246916	Map
TX	Exelixis Clinical Site #50	Plano75075	NCT05176483	Map
TX	UT Southwestern Clinical Center at Richardson/Plano	Richardson75080	NCT05987241	Map
TX	Exelixis Clinical Site #70	Tyler75601	NCT05176483	Map
TX	Texas Oncology-Tyler, Northeast Texas Cancer Institute	Tyler75702	NCT06246916	Map
TX	The University of Texas Health Science Center at Tyler dba UT Health East Texas HOPE Cancer Center	Tyler75701	NCT06561386	Map
TX	Texas Oncology - Weslaco, Knapp Medical Plaza	Weslaco78596	NCT06246916	Map
UT	Intermountain Health	Murray84107	NCT06264180	Map
UT	Huntsman Cancer Institute	Salt Lake City84112	NCT06264180	Map
UT	Huntsman Cancer Institute, University of Utah	Salt Lake City84112	NCT06743126	Map
UT	Huntsman Cancer Institute/University of Utah	Salt Lake City84112	NCT05987241	Map
UT	University of Utah Huntsman Cancer Institute	Salt Lake City84112	NCT06112314	Map
UT	University of Utah Huntsman Cancer Institute	Salt Lake City84112	NCT06246916	Map
VT	Central Vermont Medical Center/National Life Cancer Treatment	Berlin Corners05602	NCT05987241	Map
VT	University of Vermont and State Agricultural College	Burlington05405	NCT05987241	Map
VT	University of Vermont Medical Center	Burlington05401	NCT05987241	Map
VT	University of Vermont Medical Center	Burlington05401	NCT06264180	Map
VA	Exelixis Clinical Site #66	Charlottesville22903	NCT05176483	Map
VA	University of Virginia	Charlottesville22908	NCT06246916	Map
VA	University of Virginia Cancer Center	Charlottesville22908	NCT05987241	Map
VA	UVA Health-UVA Emily Couric Clinical Cancer Center	Charlottesville22903	NCT06112314	Map
VA	Inova Schar Cancer Institute	Fairfax22031	NCT06246916	Map
VA	Virginia Cancer Specialists, PC	Fairfax22031	NCT06246916	Map
VA	Bon Secours Memorial Regional Medical Center	Mechanicsville23116	NCT05987241	Map
VA	Bon Secours Saint Francis Medical Center	Midlothian23114	NCT05987241	Map
VA	Virginia Oncology Associates	Norfolk23502	NCT06246916	Map
VA	Bon Secours Richmond Community Hospital	Richmond23223	NCT05987241	Map
VA	Bon Secours Saint Mary's Hospital	Richmond23226	NCT05987241	Map
VA	VCU Massey Cancer Center at Stony Point	Richmond23235	NCT05987241	Map
VA	VCU Massey Comprehensive Cancer Center	Richmond23298	NCT05987241	Map
VA	Virginia Commonwealth University	Richmond23219	NCT06743126	Map
VA	Virginia Commonwealth University (VCU) - Massey Cancer Center	Richmond23298-0070	NCT06112314	Map
VA	Virginia Commonwealth University Massey Cancer Center	Richmond23298	NCT06246916	Map
VA	Oncology & Hematology Associates of Southwest Virginia, Inc.	Roanoke24014	NCT06246916	Map
VA	VCU Community Memorial Health Center	South Hill23970	NCT05987241	Map
WA	Swedish Cancer Institute - Edmonds Campus	Edmonds98026	NCT06246916	Map
WA	Swedish Cancer Institute - Issaquah Campus	Issaquah98029	NCT06246916	Map
WA	Kadlec Clinic Hematology and Oncology	Kennewick99336	NCT06246916	Map
WA	Fred Hutchinson Cancer Center	Seattle98109	NCT06697197	Map
WA	Fred Hutchinson Cancer Center	Seattle98109	NCT06743126	Map
WA	Swedish Cancer Institute	Seattle98104	NCT06246916	Map
WA	Swedish Medical Center - Swedish Cancer Institute (SCI) - First Hill Campus	Seattle98104	NCT06112314	Map
WA	Swedish Medical Center-First Hill	Seattle98122	NCT06029270	Map
WA	Virginia Mason Medical Center	Seattle98101	NCT05987241	Map
WV	West Virginia University Charleston Division	Charleston25304	NCT05987241	Map
WV	West Virginia University	Morgantown26506	NCT06246916	Map
WV	West Virginia University	Morgantown26506	NCT06264180	Map
WV	West Virginia University Healthcare	Morgantown26506	NCT05987241	Map
WI	ThedaCare Regional Cancer Center	Appleton54911	NCT05987241	Map
WI	Aurora Saint Luke's South Shore	Cudahy53110	NCT05987241	Map
WI	Marshfield Medical Center-EC Cancer Center	Eau Claire54701	NCT05987241	Map
WI	Aurora Cancer Care-Grafton	Grafton53024	NCT05987241	Map
WI	Aurora BayCare Medical Center	Green Bay54311	NCT05987241	Map
WI	Saint Vincent Hospital Cancer Center at Saint Mary's	Green Bay54303	NCT05987241	Map
WI	Saint Vincent Hospital Cancer Center Green Bay	Green Bay54301	NCT05987241	Map
WI	University of Wisconsin Carbone Cancer Center	Madison53792	NCT06246916	Map
WI	University of Wisconsin Carbone Cancer Center - Eastpark Medical Center	Madison53718	NCT05987241	Map
WI	University of Wisconsin Carbone Cancer Center - University Hospital	Madison53792	NCT05987241	Map
WI	UW Hospital and Clinics	Madison53792	NCT07281924	Map
WI	Aurora Bay Area Medical Group-Marinette	Marinette54143	NCT05987241	Map
WI	Marshfield Medical Center-Marshfield	Marshfield54449	NCT05987241	Map
WI	Aurora Saint Luke's Medical Center	Milwaukee53215	NCT05987241	Map
WI	Aurora Sinai Medical Center	Milwaukee53233	NCT05987241	Map
WI	Exelixis Clinical Site #33	Milwaukee53226	NCT05176483	Map
WI	Medical College of Wisconsin	Milwaukee53226	NCT05987241	Map
WI	ProHealth D N Greenwald Center	Mukwonago53149	NCT05987241	Map
WI	ProHealth D N Greenwald Center	Mukwonago53149	NCT06029270	Map
WI	ProHealth Oconomowoc Memorial Hospital	Oconomowoc53066	NCT05987241	Map
WI	ProHealth Oconomowoc Memorial Hospital	Oconomowoc53066	NCT06029270	Map
WI	Saint Vincent Hospital Cancer Center at Oconto Falls	Oconto Falls54154	NCT05987241	Map
WI	Vince Lombardi Cancer Clinic - Oshkosh	Oshkosh54904	NCT05987241	Map
WI	Saint Vincent Hospital Cancer Center at Sheboygan	Sheboygan53081	NCT05987241	Map
WI	Vince Lombardi Cancer Clinic-Sheboygan	Sheboygan53081	NCT05987241	Map
WI	Marshfield Medical Center-River Region at Stevens Point	Stevens Point54482	NCT05987241	Map
WI	Saint Vincent Hospital Cancer Center at Sturgeon Bay	Sturgeon Bay54235-1495	NCT05987241	Map
WI	Aurora Medical Center in Summit	Summit53066	NCT05987241	—
WI	Vince Lombardi Cancer Clinic-Two Rivers	Two Rivers54241	NCT05987241	Map
WI	ProHealth Waukesha Memorial Hospital	Waukesha53188	NCT05987241	Map
WI	ProHealth Waukesha Memorial Hospital	Waukesha53188	NCT06029270	Map
WI	UW Cancer Center at ProHealth Care	Waukesha53188	NCT05987241	Map
WI	UW Cancer Center at ProHealth Care	Waukesha53188	NCT06029270	Map
WI	Aurora Cancer Care-Milwaukee West	Wauwatosa53226	NCT05987241	Map
WI	Aurora West Allis Medical Center	West Allis53227	NCT05987241	Map
WI	Marshfield Medical Center - Weston	Weston54476	NCT05987241	Map

Relatlimab clinical trials at a glance: phase × recruitment status

Phase	recruiting	active not recruiting	completed	terminated	withdrawn	suspended	not yet recruiting	unknown	no longer available	Total
Early P1			1							1
P1	2	3	4	2						11
P1/P2	3	1	6	1			1			12
P2	15	12	11	3	2	1	2	2		48
P2/P3	2	1								3
P3	5	1		2						8
P4	1						1			2
N/A	1		2						2	5

Recruiting Relatlimab clinical trials (33)

Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).

NCT ID	Title	Phase	Indication	Enrollment	Started
NCT07369791	NOBLENivolumab Plus Relatlimab and Gemcitabine/Cisplatin as First-Line Treatment in Advanced Biliary Tract Cancer.	P2	Advanced Biliary Tract Cancer(BTC)	76	May 2026
NCT06999980	Neo IRENIENeo IRENIE (NEOadjuvant Ipilimumab, RElatlimab, NIvolumab Evaluation)	P2	Cutaneous Melanoma	494	Feb 2026
NCT06288191	Neoadjuvant Nivolumab and Relatlimab in Cutaneous Squamous Cell Carcinoma	P2	Cutaneous Squamous Cell Carcinoma	20	Jun 2024
NCT06264180	VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]	P3	Advanced Melanoma	400	Jul 2024
NCT06151236	Neoadjuvant Nivolumab and Relatlimab in Merkel Cell Carcinoma	P2	Merkel Cell Carcinoma	20	Mar 2024
NCT06246916	A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)	P3	Melanoma	560	Sep 2024
NCT06683755	TRINITYPhase I/IIa Dose Finding Study of Triplet Regimen of Relatlimab Ipilimumab and NIvolumab in First Line Therapy of Metastatic Melanoma (TRINITY)	P1/P2	Melanoma	30	May 2025
NCT06561386	RELATIVITY1093A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%	P3	Non-small Cell Lung Cancer	1,000	Oct 2024
NCT03521830	Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma	P2	Basal Cell Carcinoma	57	Nov 2018
NCT07492680	A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)	P2	Solid Tumors	260	Jul 2026
NCT07223411	Opdualag vs. Cemiplimab/Fianlimab in Relation to the Immunological Response in Tumor and Peripheral Blood in Unresectable or Metastatic Melanoma	—	Locally Advanced Melanoma	20	Nov 2025
NCT06743126	SUPRAMESUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma	P3	Melanoma, Cutaneous Malignant	360	Jan 2025
NCT06816927	GIANTTrial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab	P2	Newly Diagnosed Glioblastoma	92	Nov 2025
NCT07504796	ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab	P4	Metastatic Melanoma	90	Apr 2026
NCT06624644	A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma	P2/P3	Melanoma (Skin Cancer)	135	Aug 2025
NCT07281924	Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis	P1/P2	Metastatic Melanoma	15	Jun 2026
NCT06963905	SIMONESaci Nivo Rela for TNBC	P1/P2	Metastatic Triple-negative Breast Cancer	60	Dec 2025
NCT05987241	Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study	P2/P3	Muscle Invasive Bladder Urothelial Carcinoma	992	Feb 2024
NCT05176483	STELLAR-002Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors	P1	Renal Cell Carcinoma (RCC)	1,314	Dec 2021
NCT06712927	Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain Metastases	P2	Melanoma	60	Aug 2025
NCT03899155	Pan Tumor Rollover Study	P2	Cancer	1,500	Aug 2019
NCT07459543	FDCA Study To Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Untreated, Unresectable or Metastatic Melanoma Participants In India	P4	Untreated Melanoma	30	Nov 2026
NCT06029270	Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer	P2	Metastatic Nasopharyngeal Carcinoma	156	Jul 2024
NCT06697197	A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors	P1/P2	Advanced Solid Tumors	413	Feb 2025
NCT06708949	RCCA Randomized Phase 2 Trial of Nivolumab, Relatlimab Plus Ipilimumab vs. Nivolumab Plus Ipilimumab in First-line Advanced Renal Cell Carcinoma (RCC)	P2	Renal Cell Carcinoma, Clear Cell	15	Mar 2025
NCT06295159	Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma	P2	Melanoma Stage III	90	May 2024
NCT06237920	TURANDORELAStage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab	P2	Urologic Neoplasms	90	Feb 2024
NCT05704647	Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain Metastases	P2	Melanoma (Skin)	30	Feb 2023
NCT06624475	NEONNeoadjuvant Nivolumab + Relatlimab (Opdualag) Versus Nivolumab for Resectable High-Risk Basal Cell Carcinoma	P2	Basal Cell Carcinoma	30	Aug 2025
NCT05428007	Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma	P2	Melanoma	105	Feb 2023
NCT04697576	Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma	P1	Clinical Stage I Cutaneous Melanoma AJCC v8	36	Oct 2021
NCT04204837	Nivolumab for Treatment of Squamous Cell Carcinoma of the Skin	P2	Squamous Cell Carcinoma of the Skin	61	Mar 2017
NCT06112314	PRISM-MEL-301IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)	P3	Advanced Melanoma	680	Jun 2024

Relatlimab clinical trials by indication

Melanoma (12)

NCT	Acronym	Phase	Status	Title
NCT06246916	—	P3	recruiting	A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
NCT06683755	TRINITY	P1/P2	not yet recruiting	Phase I/IIa Dose Finding Study of Triplet Regimen of Relatlimab Ipilimumab and NIvolumab in First Line Therapy of Metastatic Melanoma (TRINITY)
NCT03470922	RELATIVITY-047	P2/P3	active not recruiting	A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma
NCT06712927	—	P2	recruiting	Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain Metastases
NCT05428007	—	P2	recruiting	Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma
NCT05625399	RELATIVITY-127	P3	active not recruiting	A Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination (FDC) in Previously Untreated Metastatic or Unresectable Melanoma
NCT06101134	—	P2	active not recruiting	A Study to Evaluate Whether Participants With Melanoma Prefer Subcutaneous vs Intravenous Administration of Nivolumab and Nivolumab + Relatlimab Fixed-dose Combinations
NCT05912244	—	P2	active not recruiting	A Study of IO102/IO103, Nivolumab, and Relatlimab in People With Melanoma
+ 4 more, see All trials below.

Metastatic Melanoma (6)

NCT	Acronym	Phase	Status	Title
NCT07504796	—	P4	recruiting	ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab
NCT07281924	—	P1/P2	recruiting	Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis
NCT05034536	—	P2	active not recruiting	PD-1 Antibody Therapy + Infliximab for Metastatic Melanoma
NCT03645928	—	P2	terminated	Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors
NCT05704933	—	Early P1	completed	Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases
NCT03724968	—	P2	terminated	Nivolumab Plus Relatlimab or Ipilimumab in Metastatic Melanoma Stratified by MHC-II Expression

Advanced Cancer (4)

NCT	Acronym	Phase	Status	Title
NCT03459222	—	P1/P2	completed	An Investigational Study of Immunotherapy Combinations in Participants With Solid Cancers That Are Advanced or Have Spread
NCT02996110	FRACTION-RCC	P2	completed	A Study to Test Combination Treatments in People With Advanced Renal Cell Carcinoma
NCT03335540	ADVISE	P1	completed	An Adaptive Study to Match Patients With Solid Tumors to Various Immunotherapy Combinations Based Upon a Broad Biomarker Assessment
NCT02750514	FRACTION-Lung	P2	terminated	An Investigational Immuno-therapy Study to Test Combination Treatments in Patients With Advanced Non-Small Cell Lung Cancer

Advanced Solid Tumors (3)

NCT	Acronym	Phase	Status	Title
NCT06697197	—	P1/P2	recruiting	A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors
NCT06880549	—	P1	active not recruiting	A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors
NCT05498480	RELATIVITY-111	P1	completed	Study of Relatlimab in Combination With Nivolumab in Chinese Participants

Advanced Melanoma (3)

NCT	Acronym	Phase	Status	Title
NCT06264180	—	P3	recruiting	VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
NCT06112314	PRISM-MEL-301	P3	recruiting	IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
NCT07079644	—	N/A	completed	Outcomes of Nivolumab in Combination With Relatlimab in Patients With Advanced Melanoma in the Flatiron Database

Gastric Cancer (3)

NCT	Acronym	Phase	Status	Title
NCT03044613	—	P1	active not recruiting	Nivolumab +/- Relatlimab Prior to Chemoradiation With II/III Gastro/Esophageal Cancer
NCT04062656	IMAGINE	P2	unknown	Perioperative Immunotherapy vs. Chemo-immunotherapy in Patients With Advanced GC and AEG
NCT03704077	—	P2	withdrawn	An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma

Cancer (3)

NCT	Acronym	Phase	Status	Title
NCT03899155	—	P2	recruiting	Pan Tumor Rollover Study
NCT02966548	—	P1	completed	Safety Study of BMS-986016 With or Without Nivolumab in Patients With Advanced Solid Tumors
NCT04112498	—	P1	completed	A Phase 1, Bioavailability Study of Relatlimab in Combination With Nivolumab

Cutaneous Melanoma (2)

NCT	Acronym	Phase	Status	Title
NCT06999980	Neo IRENIE	P2	recruiting	Neo IRENIE (NEOadjuvant Ipilimumab, RElatlimab, NIvolumab Evaluation)
NCT02519322	—	P2	completed	Neoadjuvant and Adjuvant Checkpoint Blockade

Basal Cell Carcinoma (2)

NCT	Acronym	Phase	Status	Title
NCT03521830	—	P2	recruiting	Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
NCT06624475	NEON	P2	recruiting	Neoadjuvant Nivolumab + Relatlimab (Opdualag) Versus Nivolumab for Resectable High-Risk Basal Cell Carcinoma

Non-small Cell Lung Cancer (2)

NCT	Acronym	Phase	Status	Title
NCT06561386	RELATIVITY1093	P3	recruiting	A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
NCT04623775	NSCLC	P2	active not recruiting	A Study of Relatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemotherapy as First Line Treatment for Participants With Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)

Lymphoma, Non-Hodgkin (2)

NCT	Acronym	Phase	Status	Title
NCT05255601	RELATIVITY-069	P1/P2	completed	A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma
NCT03310619	PLATFORM	P1/P2	completed	A Safety and Efficacy Trial of JCAR017 Combinations in Subjects With Relapsed/Refractory B-cell Malignancies

Advanced Lymphoma (2)

NCT	Acronym	Phase	Status	Title
NCT02465060	—	P2	active not recruiting	Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
NCT06400264	—	P2	withdrawn	Testing Nivolumab and BMS-986016 (Relatlimab) as Potentially Targeting Treatment in Cancers That Are LAG-3+ and Have Mismatch Repair Deficiency (MATCH - Subprotocol Z1M)

Hepatocellular Carcinoma (2)

NCT	Acronym	Phase	Status	Title
NCT04658147	HCC	P1	active not recruiting	Feasibility and Efficacy of Perioperative Nivolumab With or Without Relatlimab for Patients With Potentially Resectable Hepatocellular Carcinoma (HCC)
NCT04567615	—	P2	completed	A Study of Relatlimab in Combination With Nivolumab in Participants With Advanced Liver Cancer Who Have Never Been Treated With Immuno-oncology Therapy After Prior Treatment With Tyrosine Kinase Inhibitors

Other (2)

NCT	Acronym	Phase	Status	Title
NCT05170659	—	N/A	no longer available	Expanded Access for Relatlimab
NCT05170685	—	N/A	no longer available	Expanded Access for Fixed-Dose Combination of Nivolumab Plus Relatlimab

Untreated Melanoma (1)

NCT	Acronym	Phase	Status	Title
NCT07459543	FDC	P4	not yet recruiting	A Study To Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Untreated, Unresectable or Metastatic Melanoma Participants In India

Solid Tumors (1)

NCT	Acronym	Phase	Status	Title
NCT07492680	—	P2	not yet recruiting	A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

Advanced Biliary Tract Cancer(BTC) (1)

NCT	Acronym	Phase	Status	Title
NCT07369791	NOBLE	P2	not yet recruiting	Nivolumab Plus Relatlimab and Gemcitabine/Cisplatin as First-Line Treatment in Advanced Biliary Tract Cancer.

Metastatic Triple-negative Breast Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT06963905	SIMONE	P1/P2	recruiting	Saci Nivo Rela for TNBC

Newly Diagnosed Glioblastoma (1)

NCT	Acronym	Phase	Status	Title
NCT06816927	GIANT	P2	recruiting	Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab

Locally Advanced Melanoma (1)

NCT	Acronym	Phase	Status	Title
NCT07223411	—	N/A	recruiting	Opdualag vs. Cemiplimab/Fianlimab in Relation to the Immunological Response in Tumor and Peripheral Blood in Unresectable or Metastatic Melanoma

Melanoma (Skin Cancer) (1)

NCT	Acronym	Phase	Status	Title
NCT06624644	—	P2/P3	recruiting	A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

Renal Cell Carcinoma, Clear Cell (1)

NCT	Acronym	Phase	Status	Title
NCT06708949	RCC	P2	recruiting	A Randomized Phase 2 Trial of Nivolumab, Relatlimab Plus Ipilimumab vs. Nivolumab Plus Ipilimumab in First-line Advanced Renal Cell Carcinoma (RCC)

Melanoma, Cutaneous Malignant (1)

NCT	Acronym	Phase	Status	Title
NCT06743126	SUPRAME	P3	recruiting	SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma

LOCALLY ADVANCED CERVICAL CANCERS (1)

NCT	Acronym	Phase	Status	Title
NCT06715241	COLIBRI-2	P2	active not recruiting	A MULTICENTER, SEEKING SIGNAL, RANDOMISED, OPEN-LABEL PHASE II OF RELATLIMAB AND NIVOLUMAB VS NIVOLUMAB ALONE IN LOCALLY ADVANCED CERVICAL CANCERS

Progressive Glioblastoma (1)

NCT	Acronym	Phase	Status	Title
NCT06325683	—	P2	suspended	Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma

Metastatic Nasopharyngeal Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT06029270	—	P2	recruiting	Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

Cutaneous Squamous Cell Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT06288191	—	P2	recruiting	Neoadjuvant Nivolumab and Relatlimab in Cutaneous Squamous Cell Carcinoma

Melanoma Stage III (1)

NCT	Acronym	Phase	Status	Title
NCT06295159	—	P2	recruiting	Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma

Merkel Cell Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT06151236	—	P2	recruiting	Neoadjuvant Nivolumab and Relatlimab in Merkel Cell Carcinoma

Urologic Neoplasms (1)

NCT	Acronym	Phase	Status	Title
NCT06237920	TURANDORELA	P2	recruiting	Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab

Muscle Invasive Bladder Urothelial Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT05987241	—	P2/P3	recruiting	Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

Stage II Melanoma (1)

NCT	Acronym	Phase	Status	Title
NCT05418972	Neo ReNi II	P2	active not recruiting	A Phase 2 Clinical Trial of Neoadjuvant Relatlimab and Nivolumab in High Risk, Clinical Stage II Cutaneous Melanoma

Melanoma (Skin) (1)

NCT	Acronym	Phase	Status	Title
NCT05704647	—	P2	recruiting	Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain Metastases

Carcinomas (1)

NCT	Acronym	Phase	Status	Title
NCT05347212	—	P2	active not recruiting	Phase II Trial of Immunotherapy in Patients With Carcinomas Arising From the Renal Medulla

Carcinoma, Hepatocellular (1)

NCT	Acronym	Phase	Status	Title
NCT05337137	RELATIVITY-106	P1/P2	completed	A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer

Renal Cell Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT05148546	NESCIO	P2	active not recruiting	Neoadjuvant Study With Combination Immuno-oncology for Primary Clear Cell Renal Cell Cancer

Colorectal Neoplasms (1)

NCT	Acronym	Phase	Status	Title
NCT05328908	RELATIVITY-123	P3	terminated	A Study of Nivolumab-relatlimab Fixed-dose Combination Versus Regorafenib or TAS-102 in Participants With Later-lines of Metastatic Colorectal Cancer

Renal Cell Carcinoma (RCC) (1)

NCT	Acronym	Phase	Status	Title
NCT05176483	STELLAR-002	P1	recruiting	Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors

Clinical Stage I Cutaneous Melanoma AJCC v8 (1)

NCT	Acronym	Phase	Status	Title
NCT04697576	—	P1	recruiting	Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma

Locally Advanced Bladder Urothelial Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT04953104	—	P2	active not recruiting	ARID1A and/or KDM6A Mutation and CXCL13 Expression

Metastatic Uveal Melanoma in the Liver (1)

NCT	Acronym	Phase	Status	Title
NCT04935229	PERIO	P1	terminated	Intrahepatic Delivery of SD-101 by Pressure-Enabled Regional Immuno-oncology (PERIO), With Checkpoint Blockade in Adults With Metastatic Uveal Melanoma

Acute Myeloid Leukemia (1)

NCT	Acronym	Phase	Status	Title
NCT04913922	AARON	P2	unknown	Relatlimab With Nivolumab and 5-Azacytidine for the Treatment of AML

Metastatic Ovarian Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT04611126	—	P1/P2	terminated	T-cell Therapy in Combination With Nivolumab, Relatlimab and Ipilimumab for Patients With Metastatic Ovarian Cancer

Metastatic Uveal Melanoma (1)

NCT	Acronym	Phase	Status	Title
NCT04552223	—	P2	completed	Nivolumab Plus Relatlimab in Patients With Metastatic Uveal Melanoma

Squamous Cell Carcinoma of the Head and Neck (1)

NCT	Acronym	Phase	Status	Title
NCT04326257	—	P2	completed	Personalized Immunotherapy in Patients With Recurrent /Metastatic SCCHN That Have Progressed on Prior Immunotherapy

NSCLC Stage II (1)

NCT	Acronym	Phase	Status	Title
NCT04205552	NEOpredict	P2	completed	Neoadjuvant Nivolumab Combination Treatment in Resectable Non-small Cell Lung Cancer Patients

Soft Tissue Sarcoma Adult (1)

NCT	Acronym	Phase	Status	Title
NCT04095208	CONGRATS	P2	completed	Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study

Head and Neck Squamous Cell Carcinoma (HNSCC) (1)

NCT	Acronym	Phase	Status	Title
NCT04080804	—	P2	active not recruiting	Study of Safety and Tolerability of Nivolumab Treatment Alone or in Combination With Relatlimab or Ipilimumab in Head and Neck Cancer

Chordoma (1)

NCT	Acronym	Phase	Status	Title
NCT03623854	—	P2	completed	Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma

Gastroesophageal Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT03610711	REACTION	P1/P2	active not recruiting	REACTION (Radiation Enhanced Assessment of Combination Therapies in Immuno-ONcology) - Nivolumab or Nivolumab in Combination With Other Immuno-oncology (IO) Agents After Targeted Systemic Radiation in Patients With Advanced Esophagogastric Cancer

Microsatellite Stable (MSS) Colorectal Adenocarcinomas (1)

NCT	Acronym	Phase	Status	Title
NCT03642067	MSS	P2	completed	Study of Nivolumab and Relatlimab in Patients With Microsatellite Stable (MSS) Advanced Colorectal Cancer

Refractory MSI - H Solid Tumors Prior of PD-(L) 1 Therapy (1)

NCT	Acronym	Phase	Status	Title
NCT03607890	L	P2	active not recruiting	Study of Nivolumab and Relatlimab in Advanced Mismatch Repair Deficient Cancers Resistant to Prior PD-(L)1 Inhibitor

Squamous Cell Carcinoma of the Skin (1)

NCT	Acronym	Phase	Status	Title
NCT04204837	—	P2	recruiting	Nivolumab for Treatment of Squamous Cell Carcinoma of the Skin

Advanced Gastric Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT02935634	FRACTION-GC	P2	completed	A Study to Test Combination Treatments in Participants With Advanced Gastric Cancer

Various Advanced Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT02488759	CheckMate358	P1/P2	completed	An Investigational Immuno-therapy Study to Investigate the Safety and Effectiveness of Nivolumab, and Nivolumab Combination Therapy in Virus-associated Tumors

Neoplasms by Site (1)

NCT	Acronym	Phase	Status	Title
NCT01968109	—	P1/P2	completed	An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors

Relatlimab pivotal trial highlights (Phase 2/3/4)

Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.

Acronym	NCT	Phase	Status	Indication	Enrollment	PubMed
FDC	NCT07459543	P4	not yet recruiting	Untreated Melanoma	30	—
RELATIVITY1093	NCT06561386	P3	recruiting	Non-small Cell Lung Cancer	1,000	—
SUPRAME	NCT06743126	P3	recruiting	Melanoma, Cutaneous Malignant	360	—
RELATIVITY-127	NCT05625399	P3	active not recruiting	Melanoma	579	—
PRISM-MEL-301	NCT06112314	P3	recruiting	Advanced Melanoma	680	—
RELATIVITY-123	NCT05328908	P3	terminated	Colorectal Neoplasms	770	—
RELATIVITY-098	NCT05002569	P3	terminated	Melanoma	1,093	PMID 41109920
NOBLE	NCT07369791	P2	not yet recruiting	Advanced Biliary Tract Cancer(BTC)	76	—
Neo IRENIE	NCT06999980	P2	recruiting	Cutaneous Melanoma	494	—
Neo ReNi II	NCT05418972	P2	active not recruiting	Stage II Melanoma	20	—
GIANT	NCT06816927	P2	recruiting	Newly Diagnosed Glioblastoma	92	PMID 40016450
COLIBRI-2	NCT06715241	P2	active not recruiting	LOCALLY ADVANCED CERVICAL CANCERS	77	—
NESCIO	NCT05148546	P2	active not recruiting	Renal Cell Carcinoma	69	—
RCC	NCT06708949	P2	recruiting	Renal Cell Carcinoma, Clear Cell	15	—
TURANDORELA	NCT06237920	P2	recruiting	Urologic Neoplasms	90	—
NEON	NCT06624475	P2	recruiting	Basal Cell Carcinoma	30	—
L	NCT03607890	P2	active not recruiting	Refractory MSI - H Solid Tumors Prior of PD-(L) 1 Therapy	38	—
AARON	NCT04913922	P2	unknown	Acute Myeloid Leukemia	30	—
CONGRATS	NCT04095208	P2	completed	Soft Tissue Sarcoma Adult	68	—
NSCLC	NCT04623775	P2	active not recruiting	Non-small Cell Lung Cancer	468	—
NEOpredict	NCT04205552	P2	completed	NSCLC Stage II	90	PMID 38689060
IMAGINE	NCT04062656	P2	unknown	Gastric Cancer	21	PMID 40340830
MSS	NCT03642067	P2	completed	Microsatellite Stable (MSS) Colorectal Adenocarcinomas	59	—
FRACTION-GC	NCT02935634	P2	completed	Advanced Gastric Cancer	190	—
FRACTION-RCC	NCT02996110	P2	completed	Advanced Cancer	182	PMID 36328377
FRACTION-Lung	NCT02750514	P2	terminated	Advanced Cancer	295	—

Terminated and withdrawn Relatlimab trials (11)

Studies that ended before completion. Reasons are filed in each trial's ClinicalTrials.gov entry.

NCT06325683suspendedAnti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma
NCT03645928terminatedStudy of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors
NCT05328908terminatedA Study of Nivolumab-relatlimab Fixed-dose Combination Versus Regorafenib or TAS-102 in Participants With Later-lines of Metastatic Colorectal Cancer
NCT05002569terminatedA Study to Assess Adjuvant Immunotherapy With Nivolumab Plus Relatlimab Versus Nivolumab Alone After Complete Resection of Stage III-IV Melanoma
NCT03704077withdrawnAn Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
NCT04935229terminatedIntrahepatic Delivery of SD-101 by Pressure-Enabled Regional Immuno-oncology (PERIO), With Checkpoint Blockade in Adults With Metastatic Uveal Melanoma
NCT04611126terminatedT-cell Therapy in Combination With Nivolumab, Relatlimab and Ipilimumab for Patients With Metastatic Ovarian Cancer
NCT03978611terminatedA Study to Assess Safety of Relatlimab With Ipilimumab in Participants With Advanced Melanoma Who Progressed on Anti-Programmed Cell Death Protein 1 (Anti-PD-1) Treatment
NCT06400264withdrawnTesting Nivolumab and BMS-986016 (Relatlimab) as Potentially Targeting Treatment in Cancers That Are LAG-3+ and Have Mismatch Repair Deficiency (MATCH - Subprotocol Z1M)
NCT03724968terminatedNivolumab Plus Relatlimab or Ipilimumab in Metastatic Melanoma Stratified by MHC-II Expression
NCT02750514terminatedAn Investigational Immuno-therapy Study to Test Combination Treatments in Patients With Advanced Non-Small Cell Lung Cancer

All Relatlimab trials (90)

Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.

NCT ID	Acronym	Title	Phase	Status	Enrollment	Sponsor	Started
NCT07369791	NOBLE	Nivolumab Plus Relatlimab and Gemcitabine/Cisplatin as First-Line Treatment in Advanced Biliary Tract Cancer.	P2	not yet recruiting	76	National Health Research Institutes, Taiwan	May 2026
NCT06999980	Neo IRENIE	Neo IRENIE (NEOadjuvant Ipilimumab, RElatlimab, NIvolumab Evaluation)	P2	recruiting	494	Melanoma Institute Australia	Feb 2026
NCT06288191		Neoadjuvant Nivolumab and Relatlimab in Cutaneous Squamous Cell Carcinoma	P2	recruiting	20	Melanoma Institute Australia	Jun 2024
NCT05418972	Neo ReNi II	A Phase 2 Clinical Trial of Neoadjuvant Relatlimab and Nivolumab in High Risk, Clinical Stage II Cutaneous Melanoma	P2	active not recruiting	20	Melanoma Institute Australia	Aug 2023
NCT06264180		VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]	P3	recruiting	400	Replimune, Inc.	Jul 2024
NCT06151236		Neoadjuvant Nivolumab and Relatlimab in Merkel Cell Carcinoma	P2	recruiting	20	Melanoma Institute Australia	Mar 2024
NCT06246916		A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)	P3	recruiting	560	Regeneron Pharmaceuticals	Sep 2024
NCT06683755	TRINITY	Phase I/IIa Dose Finding Study of Triplet Regimen of Relatlimab Ipilimumab and NIvolumab in First Line Therapy of Metastatic Melanoma (TRINITY)	P1/P2	not yet recruiting	30	M.D. Anderson Cancer Center	May 2025
NCT06561386	RELATIVITY1093	A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%	P3	recruiting	1,000	Bristol-Myers Squibb	Oct 2024
NCT03521830		Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma	P2	recruiting	57	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	Nov 2018
NCT07492680		A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)	P2	not yet recruiting	260	Bristol-Myers Squibb	Jul 2026
NCT07223411		Opdualag vs. Cemiplimab/Fianlimab in Relation to the Immunological Response in Tumor and Peripheral Blood in Unresectable or Metastatic Melanoma	—	recruiting	20	John Kirkwood	Nov 2025
NCT06743126	SUPRAME	SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma	P3	recruiting	360	Immatics US, Inc.	Jan 2025
NCT06816927	GIANT	Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab	P2	recruiting	92	Duke University	Nov 2025
NCT07504796		ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab	P4	recruiting	90	NYU Langone Health	Apr 2026
NCT06624644		A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma	P2/P3	recruiting	135	Linnaeus Therapeutics, Inc.	Aug 2025
NCT07281924		Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis	P1/P2	recruiting	15	University of Wisconsin, Madison	Jun 2026
NCT06963905	SIMONE	Saci Nivo Rela for TNBC	P1/P2	recruiting	60	Yale University	Dec 2025
NCT06715241	COLIBRI-2	A MULTICENTER, SEEKING SIGNAL, RANDOMISED, OPEN-LABEL PHASE II OF RELATLIMAB AND NIVOLUMAB VS NIVOLUMAB ALONE IN LOCALLY ADVANCED CERVICAL CANCERS	P2	active not recruiting	77	ARCAGY/ GINECO GROUP	Dec 2024
NCT03470922	RELATIVITY-047	A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma	P2/P3	active not recruiting	714	Bristol-Myers Squibb	Apr 2018
NCT05987241		Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study	P2/P3	recruiting	992	National Cancer Institute (NCI)	Feb 2024
NCT05176483	STELLAR-002	Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors	P1	recruiting	1,314	Exelixis	Dec 2021
NCT04658147	HCC	Feasibility and Efficacy of Perioperative Nivolumab With or Without Relatlimab for Patients With Potentially Resectable Hepatocellular Carcinoma (HCC)	P1	active not recruiting	31	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	May 2021
NCT06712927		Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain Metastases	P2	recruiting	60	Stanford University	Aug 2025
NCT03899155		Pan Tumor Rollover Study	P2	recruiting	1,500	Bristol-Myers Squibb	Aug 2019
NCT07459543	FDC	A Study To Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Untreated, Unresectable or Metastatic Melanoma Participants In India	P4	not yet recruiting	30	Bristol-Myers Squibb	Nov 2026
NCT06029270		Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer	P2	recruiting	156	National Cancer Institute (NCI)	Jul 2024
NCT05148546	NESCIO	Neoadjuvant Study With Combination Immuno-oncology for Primary Clear Cell Renal Cell Cancer	P2	active not recruiting	69	The Netherlands Cancer Institute	Apr 2022
NCT06697197		A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors	P1/P2	recruiting	413	Bristol-Myers Squibb	Feb 2025
NCT06708949	RCC	A Randomized Phase 2 Trial of Nivolumab, Relatlimab Plus Ipilimumab vs. Nivolumab Plus Ipilimumab in First-line Advanced Renal Cell Carcinoma (RCC)	P2	recruiting	15	M.D. Anderson Cancer Center	Mar 2025
NCT06295159		Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma	P2	recruiting	90	H. Lee Moffitt Cancer Center and Research Institute	May 2024
NCT06237920	TURANDORELA	Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab	P2	recruiting	90	The Netherlands Cancer Institute	Feb 2024
NCT05704647		Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain Metastases	P2	recruiting	30	M.D. Anderson Cancer Center	Feb 2023
NCT06325683		Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma	P2	suspended	184	National Cancer Institute (NCI)	Nov 2024
NCT06624475	NEON	Neoadjuvant Nivolumab + Relatlimab (Opdualag) Versus Nivolumab for Resectable High-Risk Basal Cell Carcinoma	P2	recruiting	30	University of California, San Diego	Aug 2025
NCT05428007		Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma	P2	recruiting	105	NYU Langone Health	Feb 2023
NCT05034536		PD-1 Antibody Therapy + Infliximab for Metastatic Melanoma	P2	active not recruiting	36	Massachusetts General Hospital	Feb 2022
NCT04697576		Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma	P1	recruiting	36	Carlo Contreras	Oct 2021
NCT03610711	REACTION	REACTION (Radiation Enhanced Assessment of Combination Therapies in Immuno-ONcology) - Nivolumab or Nivolumab in Combination With Other Immuno-oncology (IO) Agents After Targeted Systemic Radiation in Patients With Advanced Esophagogastric Cancer	P1/P2	active not recruiting	21	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	Mar 2019
NCT04204837		Nivolumab for Treatment of Squamous Cell Carcinoma of the Skin	P2	recruiting	61	Salzburger Landeskliniken	Mar 2017
NCT05625399	RELATIVITY-127	A Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination (FDC) in Previously Untreated Metastatic or Unresectable Melanoma	P3	active not recruiting	579	Bristol-Myers Squibb	Mar 2023
NCT06112314	PRISM-MEL-301	IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)	P3	recruiting	680	Immunocore Ltd	Jun 2024
NCT06101134		A Study to Evaluate Whether Participants With Melanoma Prefer Subcutaneous vs Intravenous Administration of Nivolumab and Nivolumab + Relatlimab Fixed-dose Combinations	P2	active not recruiting	100	Bristol-Myers Squibb	Nov 2023
NCT03044613		Nivolumab +/- Relatlimab Prior to Chemoradiation With II/III Gastro/Esophageal Cancer	P1	active not recruiting	32	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	Jul 2017
NCT06880549		A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors	P1	active not recruiting	42	ModernaTX, Inc.	Mar 2025
NCT05347212		Phase II Trial of Immunotherapy in Patients With Carcinomas Arising From the Renal Medulla	P2	active not recruiting	30	M.D. Anderson Cancer Center	Sep 2022
NCT05912244		A Study of IO102/IO103, Nivolumab, and Relatlimab in People With Melanoma	P2	active not recruiting	43	Memorial Sloan Kettering Cancer Center	Jun 2023
NCT04953104		ARID1A and/or KDM6A Mutation and CXCL13 Expression	P2	active not recruiting	6	M.D. Anderson Cancer Center	Sep 2021
NCT02465060		Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)	P2	active not recruiting	6,452	National Cancer Institute (NCI)	Aug 2015
NCT03607890	L	Study of Nivolumab and Relatlimab in Advanced Mismatch Repair Deficient Cancers Resistant to Prior PD-(L)1 Inhibitor	P2	active not recruiting	38	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	Nov 2018
NCT04080804		Study of Safety and Tolerability of Nivolumab Treatment Alone or in Combination With Relatlimab or Ipilimumab in Head and Neck Cancer	P2	active not recruiting	80	Dan Zandberg	Dec 2019
NCT04913922	AARON	Relatlimab With Nivolumab and 5-Azacytidine for the Treatment of AML	P2	unknown	30	Ludwig-Maximilians - University of Munich	May 2021
NCT04095208	CONGRATS	Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study	P2	completed	68	Institut Bergonié	Feb 2020
NCT04623775	NSCLC	A Study of Relatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemotherapy as First Line Treatment for Participants With Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)	P2	active not recruiting	468	Bristol-Myers Squibb	Feb 2021
NCT03645928		Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors	P2	terminated	225	Iovance Biotherapeutics, Inc.	May 2019
NCT04552223		Nivolumab Plus Relatlimab in Patients With Metastatic Uveal Melanoma	P2	completed	27	Jose Lutzky, MD	Nov 2020
NCT05255601	RELATIVITY-069	A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma	P1/P2	completed	5	Bristol-Myers Squibb	Sep 2022
NCT04205552	NEOpredict	Neoadjuvant Nivolumab Combination Treatment in Resectable Non-small Cell Lung Cancer Patients	P2	completed	90	University Hospital, Essen	Mar 2020
NCT04567615		A Study of Relatlimab in Combination With Nivolumab in Participants With Advanced Liver Cancer Who Have Never Been Treated With Immuno-oncology Therapy After Prior Treatment With Tyrosine Kinase Inhibitors	P2	completed	266	Bristol-Myers Squibb	Feb 2021
NCT05337137	RELATIVITY-106	A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer	P1/P2	completed	83	Bristol-Myers Squibb	May 2022
NCT07091695		Real-world Outcomes Among Patients With Melanoma Treated With Neoadjuvant Nivolumab+Relatlimab or Nivolumab+Ipilimumab	—	completed	100	Bristol-Myers Squibb	May 2025
NCT05328908	RELATIVITY-123	A Study of Nivolumab-relatlimab Fixed-dose Combination Versus Regorafenib or TAS-102 in Participants With Later-lines of Metastatic Colorectal Cancer	P3	terminated	770	Bristol-Myers Squibb	Apr 2022
NCT04062656	IMAGINE	Perioperative Immunotherapy vs. Chemo-immunotherapy in Patients With Advanced GC and AEG	P2	unknown	21	University Hospital, Essen	Sep 2019
NCT05002569	RELATIVITY-098	A Study to Assess Adjuvant Immunotherapy With Nivolumab Plus Relatlimab Versus Nivolumab Alone After Complete Resection of Stage III-IV Melanoma	P3	terminated	1,093	Bristol-Myers Squibb	Oct 2021
NCT07079644		Outcomes of Nivolumab in Combination With Relatlimab in Patients With Advanced Melanoma in the Flatiron Database	—	completed	678	Bristol-Myers Squibb	Nov 2024
NCT03459222		An Investigational Study of Immunotherapy Combinations in Participants With Solid Cancers That Are Advanced or Have Spread	P1/P2	completed	229	Bristol-Myers Squibb	May 2018
NCT01968109		An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors	P1/P2	completed	1,482	Bristol-Myers Squibb	Nov 2013
NCT03704077		An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma	P2	withdrawn	0	Bristol-Myers Squibb	Oct 2019
NCT03642067	MSS	Study of Nivolumab and Relatlimab in Patients With Microsatellite Stable (MSS) Advanced Colorectal Cancer	P2	completed	59	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	Feb 2019
NCT05704933		Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases	Early P1	completed	1	H. Lee Moffitt Cancer Center and Research Institute	Jun 2023
NCT04326257		Personalized Immunotherapy in Patients With Recurrent /Metastatic SCCHN That Have Progressed on Prior Immunotherapy	P2	completed	20	Dan Zandberg	May 2020
NCT04935229	PERIO	Intrahepatic Delivery of SD-101 by Pressure-Enabled Regional Immuno-oncology (PERIO), With Checkpoint Blockade in Adults With Metastatic Uveal Melanoma	P1	terminated	67	TriSalus Life Sciences, Inc.	Aug 2021
NCT02966548		Safety Study of BMS-986016 With or Without Nivolumab in Patients With Advanced Solid Tumors	P1	completed	35	Bristol-Myers Squibb	Jan 2017
NCT03743766		Nivolumab, BMS-936558 in Combination with Relatlimab, BMS-986016 in Patients with Metastatic Melanoma Naïve to Prior Immunotherapy in the Metastatic Setting	P2	completed	42	John Kirkwood	Mar 2019
NCT04611126		T-cell Therapy in Combination With Nivolumab, Relatlimab and Ipilimumab for Patients With Metastatic Ovarian Cancer	P1/P2	terminated	6	Inge Marie Svane	Apr 2021
NCT05498480	RELATIVITY-111	Study of Relatlimab in Combination With Nivolumab in Chinese Participants	P1	completed	6	Bristol-Myers Squibb	Jul 2022
NCT03623854		Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma	P2	completed	10	Jonsson Comprehensive Cancer Center	Apr 2019
NCT03978611		A Study to Assess Safety of Relatlimab With Ipilimumab in Participants With Advanced Melanoma Who Progressed on Anti-Programmed Cell Death Protein 1 (Anti-PD-1) Treatment	P1	terminated	11	Bristol-Myers Squibb	Dec 2021
NCT04112498		A Phase 1, Bioavailability Study of Relatlimab in Combination With Nivolumab	P1	completed	24	Bristol-Myers Squibb	Oct 2019
NCT03310619	PLATFORM	A Safety and Efficacy Trial of JCAR017 Combinations in Subjects With Relapsed/Refractory B-cell Malignancies	P1/P2	completed	62	Celgene	Dec 2017
NCT02519322		Neoadjuvant and Adjuvant Checkpoint Blockade	P2	completed	53	M.D. Anderson Cancer Center	Feb 2016
NCT06400264		Testing Nivolumab and BMS-986016 (Relatlimab) as Potentially Targeting Treatment in Cancers That Are LAG-3+ and Have Mismatch Repair Deficiency (MATCH - Subprotocol Z1M)	P2	withdrawn	0	National Cancer Institute (NCI)	Feb 2022
NCT02488759	CheckMate358	An Investigational Immuno-therapy Study to Investigate the Safety and Effectiveness of Nivolumab, and Nivolumab Combination Therapy in Virus-associated Tumors	P1/P2	completed	578	Bristol-Myers Squibb	Oct 2015
NCT02935634	FRACTION-GC	A Study to Test Combination Treatments in Participants With Advanced Gastric Cancer	P2	completed	190	Bristol-Myers Squibb	Nov 2016
NCT05170659		Expanded Access for Relatlimab	—	no longer available	0	Bristol-Myers Squibb	—
NCT05170685		Expanded Access for Fixed-Dose Combination of Nivolumab Plus Relatlimab	—	no longer available	0	Bristol-Myers Squibb	—
NCT02996110	FRACTION-RCC	A Study to Test Combination Treatments in People With Advanced Renal Cell Carcinoma	P2	completed	182	Bristol-Myers Squibb	Feb 2017
NCT03335540	ADVISE	An Adaptive Study to Match Patients With Solid Tumors to Various Immunotherapy Combinations Based Upon a Broad Biomarker Assessment	P1	completed	20	Bristol-Myers Squibb	May 2018
NCT03724968		Nivolumab Plus Relatlimab or Ipilimumab in Metastatic Melanoma Stratified by MHC-II Expression	P2	terminated	2	Elizabeth Davis	Jan 2019
NCT02750514	FRACTION-Lung	An Investigational Immuno-therapy Study to Test Combination Treatments in Patients With Advanced Non-Small Cell Lung Cancer	P2	terminated	295	Bristol-Myers Squibb	May 2016

Relatlimab clinical trials: frequently asked questions

How many Relatlimab clinical trials are there?: 90 Relatlimab clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 29 are actively recruiting participants. 24 are marked completed.
Are Relatlimab clinical trials recruiting in 2026?: Yes — 29 Relatlimab trials are actively recruiting in 2026, with 843 U.S. sites across 48 states. See the recruiting trials and the per-state site list further down this page.
What conditions is Relatlimab being studied for?: Relatlimab is being studied for Melanoma, Metastatic Melanoma, Advanced Melanoma, Advanced Cancer, Gastric Cancer and 207 more. The trials are grouped by indication on this page.
What phase is Relatlimab in?: Relatlimab clinical trials span 2 Phase 4, 8 Phase 3, 48 Phase 2, 11 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
Who sponsors Relatlimab clinical trials?: The lead sponsor across the most Relatlimab trials is Bristol-Myers Squibb, with 37 additional lead sponsors listed in the data. Each trial row links to the full study detail page including sponsor information.

Sources and methodology

Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Relatlimabas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.

Last refreshed June 12, 2026.

Related pages on Hipa.ai:

Relatlimab overview Relatlimab evidence & publications